{"id":43015,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/agreement-and-plan-of-merger-and-reorganization-cmgi-inc-and.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"agreement-and-plan-of-merger-and-reorganization-cmgi-inc-and","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/agreement-and-plan-of-merger-and-reorganization-cmgi-inc-and.html","title":{"rendered":"Agreement and Plan of Merger and Reorganization &#8211; CMGI Inc. and uBid Inc."},"content":{"rendered":"<pre>\n                AGREEMENT AND PLAN OF MERGER AND REORGANIZATION\n\n\n                                 by and among\n\n\n                                  CMGI, Inc.\n\n\n                              Senlix Corporation\n\n\n                                      and\n\n\n                                  uBID, INC.\n\n\n                         Dated as of February 9, 2000\n\n\n \n                               TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n                                                                           Page<br \/>\n                                                                           &#8212;-<br \/>\n<s>                                                                        <c><br \/>\nARTICLE I THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   2<br \/>\n1.1   Effective Time of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   2<br \/>\n1.2   Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   2<br \/>\n1.3   Effects of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   2<br \/>\n1.4   Directors&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   2<br \/>\nARTICLE II CONVERSION OF SECURITIES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   3<br \/>\n2.1   Conversion of Capital Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   3<br \/>\n2.2   Exchange of Certificates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   4<br \/>\nARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY&#8230;&#8230;&#8230;&#8230;&#8230;.   7<br \/>\n3.1   Organization, Standing and Power;<br \/>\n      Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   7<br \/>\n3.2   Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   8<br \/>\n3.3   Authority; No Conflict; Required Filings<br \/>\n      and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  10<br \/>\n3.4   SEC Filings; Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  11<br \/>\n3.5   No Undisclosed Liabilities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  12<br \/>\n3.6   Absence of Certain Changes or Events&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  13<br \/>\n3.7   Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  13<br \/>\n3.8   Owned and Leased Real Properties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  15<br \/>\n3.9   Intellectual Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  16<br \/>\n3.10  Agreements, Contracts and Commitments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  17<br \/>\n3.11  Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  18<br \/>\n3.12  Environmental Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  18<br \/>\n3.13  Employee Benefit Plans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  19<br \/>\n3.14  Compliance With Laws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  22<br \/>\n3.15  Permits&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  22<br \/>\n3.16  Registration Statement; Proxy<br \/>\n      Statement\/Prospectus&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  23<br \/>\n3.17  Labor Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  23<br \/>\n3.18  Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  23<br \/>\n3.19  Business Activity Restrictions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  24<br \/>\n3.20  Year 2000 Compliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  24<br \/>\n3.21  Assets&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  25<br \/>\n3.22  No Existing Discussions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  26<br \/>\n3.23  Opinion of Financial Advisor&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  26<br \/>\n3.24  Section 203 of the DGCL Not Applicable&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  26<br \/>\n3.25  Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  26<br \/>\n3.26  Transactions with Affiliates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  26<br \/>\n3.27  Brokers; Schedule of Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  26<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       i<\/p>\n<table>\n<s>                                                                        <c><br \/>\n3.28  Privacy Issues&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  27<br \/>\nARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE BUYER AND THE<br \/>\nTRANSITORY SUBSIDIARY&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  28<br \/>\n4.1   Organization, Standing and Power&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  28<br \/>\n4.2   Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  28<br \/>\n4.3   Authority; No Conflict; Required Filings<br \/>\n      and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  29<br \/>\n4.4   SEC Filings; Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  30<br \/>\n4.5   Absence of Certain Changes or Events&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  30<br \/>\n4.6   Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  31<br \/>\n4.7   Registration Statement; Proxy<br \/>\n      Statement\/Prospectus&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  31<br \/>\n4.8   Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  31<br \/>\n4.9   Operations of the Transitory Subsidiary&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  31<br \/>\n4.10  Brokers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  31<br \/>\nARTICLE V CONDUCT OF BUSINESS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  31<br \/>\n5.1   Covenants of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  31<br \/>\n5.2   Cooperation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  35<br \/>\n5.3   Confidentiality&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  35<br \/>\nARTICLE VI ADDITIONAL AGREEMENTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  35<br \/>\n6.1   No Solicitation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  35<br \/>\n6.2   Proxy Statement\/Prospectus; Registration<br \/>\n      Statement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  37<br \/>\n6.3   Nasdaq Quotation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  38<br \/>\n6.4   Access to Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  38<br \/>\n6.5   Stockholders Meeting&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  38<br \/>\n6.6   Legal Conditions to the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  39<br \/>\n6.7   Public Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  40<br \/>\n6.8   Tax-Free Reorganization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  40<br \/>\n6.9   Affiliate Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  41<br \/>\n6.10  Nasdaq National Market Listing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  41<br \/>\n6.11  Company Stock Plans and the Company<br \/>\n      Warrants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  41<br \/>\n6.12  Stockholder Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  42<br \/>\n6.13  Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  42<\/p>\n<p>ARTICLE VII CONDITIONS TO MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  43<br \/>\n7.1   Conditions to Each Party&#8217;s Obligation To<br \/>\n      Effect the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  43<br \/>\n7.2   Additional Conditions to Obligations of<br \/>\n      the Buyer and the Transitory Subsidiary&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  44<br \/>\n7.3   Additional Conditions to Obligations of<br \/>\n      the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  45<br \/>\nARTICLE VIII TERMINATION AND AMENDMENT&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  46<br \/>\n8.1   Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  46<br \/>\n8.2   Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  48<br \/>\n<\/c><\/s><\/table>\n<p>                                       ii<\/p>\n<table>\n<s>                                                                        <c><br \/>\n8.3   Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  48<br \/>\n8.4   Amendment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  49<br \/>\n8.5   Extension; Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  50<br \/>\nARTICLE IX MISCELLANEOUS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  50<br \/>\n9.1   Nonsurvival of Representations and<br \/>\n      Warranties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  50<br \/>\n9.2   Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  50<br \/>\n9.3   Entire Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  51<br \/>\n9.4   No Third Party Beneficiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  51<br \/>\n9.5   Assignment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  51<br \/>\n9.6   Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.  52<br \/>\n9.7   Counterparts and Signature&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  52<br \/>\n9.8   Interpretation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  52<br \/>\n9.9   Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;  52<br \/>\n9.10  Remedies&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  53<br \/>\n9.11  Waiver of Jury Trial&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  53<br \/>\n9.12  Forum&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..  53<br \/>\n<\/c><\/s><\/table>\n<p>EXHIBITS<\/p>\n<p>Exhibit A       Form of Stockholder Agreement<br \/>\nExhibit B       Form of Lock-up Agreement<br \/>\nExhibit C       Form of Company Affiliate Agreement<\/p>\n<p>                                      iii<\/p>\n<p>                            TABLES OF DEFINED TERMS<\/p>\n<table>\n<caption>\n                                                            Cross Reference<br \/>\nTerms                                                       in Agreement<br \/>\n&#8212;&#8211;                                                       &#8212;&#8212;&#8212;&#8212;<br \/>\n<s>                                                         <c><br \/>\nAcquisition Proposal                                        Section 6.1(a)<br \/>\nAffiliate                                                   Section 6.9<br \/>\nAffiliate Agreement                                         Section 6.9<br \/>\nAgreement                                                   Preamble<br \/>\nAlternative Transaction                                     Section 8.3(e)<br \/>\nAntitrust Laws                                              Section 6.6(b)<br \/>\nAntitrust Order                                             Section 6.6(b)<br \/>\nBuyer                                                       Preamble<br \/>\nBuyer Balance Sheet                                         Section 4.4(b)<br \/>\nBuyer Common Stock                                          Section 2.1(c)<br \/>\nBuyer Disclosure Schedule                                   Article IV<br \/>\nBuyer Material Adverse Effect                               Section 4.1<br \/>\nBuyer Preferred Stock                                       Section 4.2<br \/>\nBuyer SEC Reports                                           Section 4.4(a)<br \/>\nCertificates                                                Section 2.2(b)<br \/>\nClosing                                                     Section 1.2<br \/>\nClosing Date                                                Section 1.2<br \/>\nCode                                                        Preamble<br \/>\nCompany                                                     Preamble<br \/>\nCompany Balance Sheet                                       Section 3.4(b)<br \/>\nCompany Common Stock                                        Section 2.1(b)<br \/>\nCompany Disclosure Schedule                                 Article III<br \/>\nCompany Employee Plans                                      Section 3.13(a)<br \/>\nCompany Intellectual Property Rights                        Section 3.9(a)<br \/>\nCompany Leases                                              Section 3.8(b)<br \/>\nCompany Material Adverse Effect                             Section 3.1<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                       iv<\/p>\n<table>\n<s>                                                         <c><br \/>\nCompany Material Contracts                                  Section 3.10<br \/>\nCompany Meeting                                             Section 3.16<br \/>\nCompany Permits                                             Section 3.15<br \/>\nCompany Preferred Stock                                     Section 3.2(a)<br \/>\nCompany Products                                            Section 3.20(b)<br \/>\nCompany SEC Reports                                         Section 3.4(a)<br \/>\nCompany Stock Options                                       Section 3.2(b)<br \/>\nCompany Stock Plans                                         Section 3.2(b)<br \/>\nCompany Systems                                             Section 3.20(b)<br \/>\nCompany Voting Proposal                                     Section 6.5(a)<br \/>\nCompany Warrants                                            Section 3.2(b)<br \/>\nConfidentiality Agreement                                   Section 5.3<br \/>\nConstituent Corporations                                    Section 1.3<br \/>\nDGCL                                                        Section 1.1<br \/>\nEffective Time                                              Section 1.1<br \/>\nEmployee Benefit Plans                                      Section 3.13(a)<br \/>\nEnvironmental Law                                           Section 3.12(b)<br \/>\nERISA Affiliate                                             Section 3.13(a)<br \/>\nERISA                                                       Section 3.13(a)<br \/>\nExchange Agent                                              Section 2.2(a)<br \/>\nExchange Fund                                               Section 2.2(a)<br \/>\nExchange Act                                                Section 3.3(c)<br \/>\nExchange Ratio                                              Section 2.1(c)<br \/>\nGovernmental Entity                                         Section 3.3(c)<br \/>\nHazardous Substance                                         Section 3.12(c)<br \/>\nHSR Act                                                     Section 3.3(c)<br \/>\nIndemnified Parties                                         Section 6.13<br \/>\nLiens                                                       Section 3.22<br \/>\nLock-up Agreement                                           Preamble<br \/>\nMerger                                                      Preamble<br \/>\n<\/c><\/s><\/table>\n<p>                                       v<\/p>\n<table>\n<s>                                                         <c><br \/>\nOutside Date                                                Section 8.1(b)<br \/>\nProxy Statement                                             Section 3.16<br \/>\nRegistration Statement                                      Section 3.16<br \/>\nRule 145                                                    Section 6.10<br \/>\nSEC                                                         Section 3.3(c)<br \/>\nSecurities Act                                              Section 3.4(a)<br \/>\nStockholder Agreement                                       Preamble<br \/>\nSubsidiary                                                  Section 3.1<br \/>\nSuperior Proposal                                           Section 6.1(a)<br \/>\nSurviving Corporation                                       Section 1.3<br \/>\nTax Returns                                                 Section 3.7(a)<br \/>\nTaxes                                                       Section 3.7(a)<br \/>\nThird Party                                                 Section 8.3(e)<br \/>\nTransitory Subsidiary                                       Preamble<br \/>\nYear 2000 Compliant                                         Section 3.20<br \/>\n<\/c><\/s><\/table>\n<p>                                       vi<\/p>\n<p>                AGREEMENT AND PLAN OF MERGER AND REORGANIZATION<\/p>\n<p>     THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this &#8220;Agreement&#8221;),<br \/>\ndated as of February 9, 2000, is by and among CMGI, Inc., a Delaware corporation<br \/>\n(the &#8220;Buyer&#8221;), Senlix Corporation, a Delaware corporation and a wholly owned<br \/>\nsubsidiary of Buyer (the &#8220;Transitory Subsidiary&#8221;), and UBID, Inc., a Delaware<br \/>\ncorporation (the &#8220;Company&#8221;).<\/p>\n<p>     WHEREAS, the Boards of Directors of the Buyer and the Company have approved<br \/>\nand declared advisable this Agreement and the Merger (as defined below);<\/p>\n<p>     WHEREAS, the combination of the Buyer and the Company shall be effected by<br \/>\nthe terms of this Agreement through a merger of the Transitory Subsidiary into<br \/>\nthe Company, as a result of which the stockholders of the Company will become<br \/>\nstockholders of the Buyer (the &#8220;Merger&#8221;);<\/p>\n<p>     WHEREAS, concurrently with the execution and delivery of this Agreement and<br \/>\nas a condition and inducement to the Buyer&#8217;s willingness to enter into this<br \/>\nAgreement, certain stockholders of the Company have entered into a Stockholder<br \/>\nAgreement dated as of the date of this Agreement in the form attached as<br \/>\nExhibit A (the &#8220;Stockholder Agreement&#8221;), pursuant to which such stockholders<br \/>\n&#8212;&#8212;&#8212;<br \/>\nhave agreed, inter alia, to give the Buyer a proxy to vote all of the shares of<br \/>\n             &#8212;&#8212;&#8212;-<br \/>\ncapital stock of the Company that such stockholders own for certain limited<br \/>\npurposes;<\/p>\n<p>     WHEREAS, concurrently with the execution and delivery of this Agreement and<br \/>\nas a condition and inducement to the Buyer&#8217;s willingness to enter into this<br \/>\nAgreement, certain stockholders and employees of the Company have entered into a<br \/>\nStockholder Lock-Up Agreement in the form attached hereto as Exhibit B (the<br \/>\n                                                             &#8212;&#8212;&#8212;<br \/>\n&#8220;Lock-Up Agreement&#8221;), pursuant to which such parties have agreed to certain<br \/>\nrestrictions relating to the disposition of Buyer Common Stock following the<br \/>\nEffective Time (as defined in Section 1.1); and<\/p>\n<p>     WHEREAS, for U.S. federal income tax purposes, it is intended that the<br \/>\nMerger shall qualify as a reorganization within the meaning of Section 368(a) of<br \/>\nthe Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).<\/p>\n<p>     NOW, THEREFORE, in consideration of the foregoing and the respective<br \/>\nrepresentations, warranties, covenants and agreements set forth below, the<br \/>\nBuyer, the Transitory Subsidiary and the Company agree as follows:<\/p>\n<p>                                   ARTICLE I<br \/>\n                                  THE MERGER<\/p>\n<p>1.1  Effective Time of the Merger.  Subject to the provisions of this Agreement,<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nprior to the Closing (as defined in Section 1.2), the Buyer shall prepare, and<br \/>\non the Closing Date (as defined in Section 1.2) or as soon as practicable<br \/>\nthereafter the Buyer shall cause to be filed with the Secretary of State of the<br \/>\nState of Delaware, a certificate of merger (the &#8220;Certificate of Merger&#8221;) in such<br \/>\nform as is required by, and executed by the Surviving Corporation (as defined in<br \/>\nSection 1.3) in accordance with, the relevant provisions of the General<br \/>\nCorporation Law of the State of Delaware (&#8220;DGCL&#8221;) and shall make all other<br \/>\nfilings or recordings required under the DGCL.  The Merger shall become<br \/>\neffective upon the filing of the Certificate of Merger with the Secretary of<br \/>\nState of the State of Delaware or at such later time as is established by the<br \/>\nBuyer and the Company and set forth in the Certificate of Merger (the &#8220;Effective<br \/>\nTime&#8221;).<\/p>\n<p>1.2  Closing.  The closing of the Merger (the &#8220;Closing&#8221;) shall take place at<br \/>\n     &#8212;&#8212;-<br \/>\n10:00 a.m., Boston time, on a date to be specified by the Buyer and the Company<br \/>\n(the &#8220;Closing Date&#8221;), which shall be no later than the second business day after<br \/>\nsatisfaction or waiver of the conditions set forth in Article VII (other than<br \/>\ndelivery of items to be delivered at the Closing and other than satisfaction of<br \/>\nthose conditions that by their nature are to be satisfied at the Closing, but<br \/>\nsubject to the delivery of such items and the satisfaction or waiver of such<br \/>\nconditions at the Closing), at the offices of Hale and Dorr LLP, 60 State<br \/>\nStreet, Boston, Massachusetts, unless another date, place or time is agreed to<br \/>\nin writing by the Buyer and the Company.<\/p>\n<p>1.3  Effects of the Merger.  At the Effective Time (i) the separate existence of<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nthe Transitory Subsidiary shall cease and the Transitory Subsidiary shall be<br \/>\nmerged with and into the Company (the Transitory Subsidiary and the Company are<br \/>\nsometimes referred to below as the &#8220;Constituent Corporations&#8221; and the Company<br \/>\nfollowing the Merger is sometimes referred to below as the &#8220;Surviving<br \/>\nCorporation&#8221;), (ii) the Certificate of Incorporation of the Company shall be<br \/>\namended so that Article FOURTH of such Certificate of Incorporation reads in its<br \/>\nentirety as follows:  &#8220;The total number of shares of all classes of stock which<br \/>\nthe Corporation shall have authority to issue is 50,000,000, all of which shall<br \/>\nconsist of common stock, $.01 par value per share,&#8221; and, as so amended, such<br \/>\nCertificate of Incorporation shall be the Certificate of Incorporation of the<br \/>\nSurviving Corporation, and (iii) the By-laws of the Transitory Subsidiary as in<br \/>\neffect immediately prior to the Effective Time shall be the By-laws of the<br \/>\nSurviving Corporation.  The Merger shall have the effects set forth in Section<br \/>\n259 of the DGCL.<\/p>\n<p>1.4  Directors.  The directors of the Transitory Subsidiary immediately prior to<br \/>\n     &#8212;&#8212;&#8212;<br \/>\nthe Effective Time shall be the initial directors of the Surviving Corporation,<br \/>\neach to hold office in accordance with the Certificate of Incorporation and By-<br \/>\nlaws of the Surviving Corporation.<\/p>\n<p>                                       2<\/p>\n<p>                                  ARTICLE II<br \/>\n                           CONVERSION OF SECURITIES<\/p>\n<p>2.1  Conversion of Capital Stock.  As of the Effective Time, by virtue of the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nMerger and without any action on the part of the holder of any shares of the<br \/>\ncapital stock of the Company or capital stock of the Transitory Subsidiary:<\/p>\n<p>(a)  Capital Stock of the Transitory Subsidiary.  Each issued and outstanding<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     share of the capital stock of the Transitory Subsidiary shall be converted<br \/>\n     into and become one fully paid and nonassessable share of common stock,<br \/>\n     $.01 par value per share, of the Surviving Corporation.<\/p>\n<p>(b)  Cancellation of Treasury Stock and Buyer-Owned Stock.  All shares of common<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     stock, $.001 par value per share, of the Company (&#8220;Company Common Stock&#8221;)<br \/>\n     that are owned by the Company and any shares of Company Common Stock owned<br \/>\n     by the Buyer or the Transitory Subsidiary shall be canceled and shall cease<br \/>\n     to exist and no stock of the Buyer or other consideration shall be<br \/>\n     delivered in exchange therefor.<\/p>\n<p>(c)  Exchange Ratio for Company Common Stock.  Subject to Section 2.2, each<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     share of Company Common Stock (other than shares to be canceled in<br \/>\n     accordance with Section 2.1(b)) issued and outstanding immediately before<br \/>\n     the Effective Time shall be automatically converted into the right to<br \/>\n     receive 0.2628 shares (the &#8220;Exchange Ratio &#8220;) of common stock, $.01 par<br \/>\n     value per share, of the Buyer (&#8220;Buyer Common Stock&#8221;).  As of the Effective<br \/>\n     Time, all such shares of Company Common Stock shall no longer be<br \/>\n     outstanding and shall automatically be canceled, and each holder of a<br \/>\n     certificate representing any such shares of Company Common Stock shall<br \/>\n     cease to have any rights with respect thereto, except the right to receive<br \/>\n     the shares of Buyer Common Stock and any cash in lieu of fractional shares<br \/>\n     of Buyer Common Stock to be issued or paid in consideration therefor upon<br \/>\n     surrender of such certificate in accordance with Section 2.2, without<br \/>\n     interest.<\/p>\n<p>(d)  Adjustments to Exchange Ratio.  The Exchange Ratio shall be adjusted to<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     reflect fully the effect of any reclassification, stock split, reverse<br \/>\n     split, stock dividend (including any dividend or distribution of securities<br \/>\n     convertible into Buyer Common Stock or Company Common Stock),<br \/>\n     reorganization, recapitalization or other like change with respect to Buyer<br \/>\n     Common Stock or Company Common Stock occurring after the date hereof and<br \/>\n     prior to the Effective Time.<\/p>\n<p>(e)  Unvested Stock.  At the Effective Time, any unvested shares of Company<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     Common Stock awarded to employees, directors or consultants pursuant to any<br \/>\n     of the Company&#8217;s plans or arrangements and outstanding immediately prior to<br \/>\n     the Effective Time shall be converted to unvested shares of Buyer Common<br \/>\n     Stock in accordance with the Exchange Ratio and shall remain subject to the<br \/>\n     same terms, <\/p>\n<p>                                       3<\/p>\n<p>     restrictions and vesting schedule as in effect immediately prior to the<br \/>\n     Effective Time, except as otherwise agreed by Buyer and the holder thereof.<br \/>\n     All outstanding rights which the Company may hold immediately prior to the<br \/>\n     Effective Time to repurchase unvested shares of Company Common Stock shall<br \/>\n     be assigned to the Buyer in the Merger and shall thereafter be exercisable<br \/>\n     by Buyer upon the same terms and conditions in effect immediately prior to<br \/>\n     the Effective Time, except that the shares purchasable pursuant to such<br \/>\n     rights and the purchase price payable per share shall be adjusted to<br \/>\n     reflect the Exchange Ratio. The Buyer shall take all steps necessary to<br \/>\n     cause the foregoing provisions of this Section 2.1(e) to occur.<\/p>\n<p>(f)  Treatment of Company Options and Company Warrants.  Outstanding Company<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     Stock Options and Company Warrants (in each case as defined in Section<br \/>\n     3.2(b)) shall be treated following the Effective Time in the manner set<br \/>\n     forth in Section 6.11.<\/p>\n<p>2.2  Exchange of Certificates.  The procedures for exchanging outstanding shares<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nof Company Common Stock for Buyer Common Stock pursuant to the Merger are as<br \/>\nfollows:<\/p>\n<p>(a)  Exchange Agent.  As of the Effective Time, the Buyer shall deposit with a<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     bank or trust company designated by the Buyer (the &#8220;Exchange Agent&#8221;), for<br \/>\n     the benefit of the holders of shares of the Company Common Stock, for<br \/>\n     exchange in accordance with this Section 2.2, through the Exchange Agent,<br \/>\n     (i) certificates representing the shares of Buyer Common Stock (such shares<br \/>\n     of Buyer Common Stock, together with any dividends or distributions with<br \/>\n     respect thereto, being hereinafter referred to as the &#8220;Exchange Fund&#8221;)<br \/>\n     issuable pursuant to Section 2.1 in exchange for outstanding shares of the<br \/>\n     Company Common Stock, (ii) cash in an amount sufficient to make payments<br \/>\n     required pursuant to Section 2.2(e), and (iii) any dividends or<br \/>\n     distributions to which holders of Certificates (as defined below) may be<br \/>\n     entitled pursuant to Section 2.2(c).<\/p>\n<p>(b)  Exchange Procedures.  As soon as reasonably practicable after the Effective<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     Time, the Exchange Agent shall mail to each holder of record of a<br \/>\n     certificate or certificates which immediately prior to the Effective Time<br \/>\n     represented outstanding shares of the Company Common Stock (the<br \/>\n     &#8220;Certificates&#8221;) whose shares were converted pursuant to Section 2.1 into<br \/>\n     the right to receive shares of Buyer Common Stock (i) a letter of<br \/>\n     transmittal (which shall specify that delivery shall be effected, and risk<br \/>\n     of loss and title to the Certificates shall pass, only upon delivery of the<br \/>\n     Certificates to the Exchange Agent and shall be in such form and have such<br \/>\n     other provisions as the Buyer may reasonably specify) and (ii) instructions<br \/>\n     for effecting the surrender of the Certificates in exchange for<br \/>\n     certificates representing shares of Buyer Common Stock (plus cash in lieu<br \/>\n     of fractional shares, if any, of Buyer Common Stock and any dividends or<br \/>\n     distributions as provided below).  Upon surrender of a Certificate for<br \/>\n     cancellation to the Exchange Agent or to such other agent or agents as may<br \/>\n     be appointed by the Buyer, <\/p>\n<p>                                       4<\/p>\n<p>     together with such letter of transmittal, duly executed, and such other<br \/>\n     documents as may reasonably be required by the Exchange Agent, the holder<br \/>\n     of such Certificate shall be entitled to receive in exchange therefor a<br \/>\n     certificate representing that number of whole shares of Buyer Common Stock<br \/>\n     which such holder has the right to receive pursuant to the provisions of<br \/>\n     this Article II with respect to the shares of Company Common Stock<br \/>\n     represented by such Certificate plus cash in lieu of fractional shares<br \/>\n     pursuant to Section 2.2(e) and any dividends or distributions pursuant to<br \/>\n     Section 2.2(c), and the Certificate so surrendered shall immediately be<br \/>\n     canceled. In the event of a transfer of ownership of Company Common Stock<br \/>\n     which is not registered in the transfer records of the Company, a<br \/>\n     certificate representing the proper number of shares of Buyer Common Stock<br \/>\n     plus cash in lieu of fractional shares pursuant to Section 2.2(e) and any<br \/>\n     dividends or distributions pursuant to Section 2.2(c) may be issued and<br \/>\n     paid to a person other than the person in whose name the Certificate so<br \/>\n     surrender is registered, if such Certificate is presented to the Exchange<br \/>\n     Agent, accompanied by all documents required to evidence and effect such<br \/>\n     transfer and by evidence that any applicable stock transfer taxes have been<br \/>\n     paid. Until surrendered as contemplated by this Section 2.2, each<br \/>\n     Certificate shall be deemed at any time after the Effective Time to<br \/>\n     represent only the right to receive upon such surrender the certificate<br \/>\n     representing shares of Buyer Common Stock plus cash in lieu of fractional<br \/>\n     shares pursuant to Section 2.2(e) and any dividends or distributions<br \/>\n     pursuant to Section 2.2(c) as contemplated by this Section 2.2.<\/p>\n<p>(c)  Distributions with Respect to Unexchanged Shares.  No dividends or other<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     distributions declared or made after the Effective Time with respect to<br \/>\n     Buyer Common Stock with a record date after the Effective Time shall be<br \/>\n     paid to the holder of any unsurrendered Certificate and no cash payment in<br \/>\n     lieu of fractional shares shall be paid to any such holder pursuant to<br \/>\n     Section 2.2(e) until the holder of record of such Certificate shall<br \/>\n     surrender such Certificate as contemplated by Section 2.2(b).  Subject to<br \/>\n     the effect of applicable laws, following surrender of any such Certificate,<br \/>\n     there shall be issued and paid to the record holder of the Certificate,<br \/>\n     (i) certificates representing whole shares of Buyer Common Stock issued in<br \/>\n     exchange therefor, without interest, (ii) at the time of such surrender,<br \/>\n     the amount of any cash payable in lieu of a fractional share of Buyer<br \/>\n     Common Stock to which such holder is entitled pursuant to Section 2.2(e)<br \/>\n     and the amount of dividends or other distributions with a record date after<br \/>\n     the Effective Time previously paid with respect to such whole shares of<br \/>\n     Buyer Common Stock, and (iii) at the appropriate payment date, the amount<br \/>\n     of dividends or other distributions with a record date after the Effective<br \/>\n     Time but prior to surrender and a payment date subsequent to surrender<br \/>\n     payable with respect to such whole shares of Buyer Common Stock.<\/p>\n<p>(d)  No Further Ownership Rights in Company Common Stock.  All shares of Buyer<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     Common Stock issued upon the surrender for exchange of Certificates in<br \/>\n     accordance with the terms hereof (including any cash or other distributions<br \/>\n     paid pursuant to Sections 2.2(c) or 2.2(e)) shall be deemed to have been<br \/>\n     issued in full <\/p>\n<p>                                       5<\/p>\n<p>     satisfaction of all rights pertaining to such shares of Company Common<br \/>\n     Stock, and from and after the Effective Time there shall be no further<br \/>\n     registration of transfers on the stock transfer books of the Surviving<br \/>\n     Corporation of the shares of Company Common Stock which were outstanding<br \/>\n     immediately prior to the Effective Time. If, after the Effective Time,<br \/>\n     Certificates are presented to the Surviving Corporation or the Exchange<br \/>\n     Agent for any reason, they shall be canceled and exchanged as provided in<br \/>\n     this Article II.<\/p>\n<p>(e)  No Fractional Shares.  No certificate or scrip representing fractional<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     shares of Buyer Common Stock shall be issued upon the surrender for<br \/>\n     exchange of Certificates, and such fractional share interests will not<br \/>\n     entitle the owner thereof to vote or to any other rights of a stockholder<br \/>\n     of the Buyer.  Notwithstanding any other provision of this Agreement, each<br \/>\n     holder of shares of Company Common Stock exchanged pursuant to the Merger<br \/>\n     who would otherwise have been entitled to receive a fraction of a share of<br \/>\n     Buyer Common Stock (after taking into account all Certificates delivered by<br \/>\n     such holder) shall receive, in lieu thereof, cash (without interest) in an<br \/>\n     amount equal to such fractional part of a share of Buyer Common Stock<br \/>\n     multiplied by the average of the last reported sales prices of the Buyer<br \/>\n     Common Stock on the Nasdaq National Market during the ten (10) consecutive<br \/>\n     trading days ending on and including the last trading day prior to the<br \/>\n     Effective Time.<\/p>\n<p>(f)  Termination of Exchange Fund.  Any portion of the Exchange Fund which<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     remains undistributed to the holders of the Certificates for 180 days after<br \/>\n     the Effective Time shall be delivered to the Buyer, upon demand, and any<br \/>\n     holder of the Certificates who has not previously complied with this<br \/>\n     Section 2.2 shall thereafter look only to the Buyer, for payment of its<br \/>\n     claim for Buyer Common Stock, any cash in lieu of fractional shares of<br \/>\n     Buyer Common Stock and any dividends or distributions with respect to Buyer<br \/>\n     Common Stock.<\/p>\n<p>(g)  No Liability.  To the extent permitted by applicable law, none of the<br \/>\n     &#8212;&#8212;&#8212;&#8212;<br \/>\n     Buyer, the Transitory Subsidiary, the Company, the Surviving Corporation or<br \/>\n     the Exchange Agent shall be liable to any holder of shares of Company<br \/>\n     Common Stock or Buyer Common Stock, as the case may be, for such shares (or<br \/>\n     dividends or distributions with respect thereto) delivered to a public<br \/>\n     official pursuant to any applicable abandoned property, escheat or similar<br \/>\n     law.  If any Certificate shall not have been surrendered prior to one year<br \/>\n     after the Effective Time (or immediately prior to such earlier date on<br \/>\n     which any shares of Buyer Common Stock, and any cash payable to the holder<br \/>\n     of such Certificate pursuant to this Article II or any dividends or<br \/>\n     distributions payable to the holder of such Certificate would otherwise<br \/>\n     escheat to or become the property of any Governmental Entity (as defined in<br \/>\n     Section 3.3(c))), any such shares of Buyer Common Stock or cash, dividends<br \/>\n     or distributions in respect of such Certificate shall, to the extent<br \/>\n     permitted by applicable law, become the property of the Surviving<\/p>\n<p>                                       6<\/p>\n<p>     Corporation, free and clear of all claims or interest of any person<br \/>\n     previously entitled thereto.<\/p>\n<p>(h)  Withholding Rights.  Each of the Buyer and the Surviving Corporation shall<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     be entitled to deduct and withhold from the consideration otherwise payable<br \/>\n     pursuant to this Agreement to any holder of shares of Company Common Stock<br \/>\n     such amounts as it is required to deduct and withhold with respect to the<br \/>\n     making of such payment under the Code, or any other applicable provision of<br \/>\n     law.  To the extent that amounts are so withheld by the Surviving<br \/>\n     Corporation or the Buyer, as the case may be, such withheld amounts shall<br \/>\n     be treated for all purposes of this Agreement as having been paid to the<br \/>\n     holder of the shares of Company Common Stock in respect of which such<br \/>\n     deduction and withholding was made by the Surviving Corporation or the<br \/>\n     Buyer, as the case may be.<\/p>\n<p>(i)  Lost Certificates.  If any Certificate shall have been lost, stolen or<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     destroyed, upon the making of an affidavit of that fact by the person<br \/>\n     claiming such Certificate to be lost, stolen or destroyed and, if required<br \/>\n     by the Surviving Corporation, the posting by such person of a bond in such<br \/>\n     reasonable amount as the Surviving Corporation may direct as indemnity<br \/>\n     against any claim that may be made against it with respect to such<br \/>\n     Certificate, the Exchange Agent will issue in exchange for such lost,<br \/>\n     stolen or destroyed Certificate the shares of Buyer Common Stock and any<br \/>\n     cash in lieu of fractional shares, and unpaid dividends and distributions<br \/>\n     on shares of Buyer Common Stock deliverable in respect thereof pursuant to<br \/>\n     this Agreement.<\/p>\n<p>                                  ARTICLE III<br \/>\n                 REPRESENTATIONS AND WARRANTIES OF THE COMPANY<\/p>\n<p>     The Company represents and warrants to the Buyer and the Transitory<br \/>\nSubsidiary that the statements contained in this Article III are true and<br \/>\ncorrect, except as set forth herein or in the Company disclosure schedule<br \/>\ndelivered by the Company to the Buyer on or before the date of this Agreement<br \/>\n(the &#8220;Company Disclosure Schedule&#8221;).  The Company Disclosure Schedule shall be<br \/>\narranged in paragraphs corresponding to the numbered paragraphs contained in<br \/>\nArticle III and the disclosure in any paragraph shall qualify other paragraphs<br \/>\nin this Article III only to the extent that it is reasonably apparent from a<br \/>\nreading of such disclosure that it also qualifies or applies to such other<br \/>\nparagraphs.<\/p>\n<p>3.1  Organization, Standing and Power; Subsidiaries.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n(a)  Each of the Company and its Subsidiaries (as defined below) is a<br \/>\n     corporation duly organized, validly existing and in good standing under the<br \/>\n     laws of the jurisdiction of its incorporation, has all requisite corporate<br \/>\n     power and authority to own, lease and operate its properties and assets and<br \/>\n     to carry on its business as now being conducted and as proposed to be<br \/>\n     conducted, and is duly qualified to do business and is <\/p>\n<p>                                       7<\/p>\n<p>     in good standing as a foreign corporation in each jurisdiction in which the<br \/>\n     failure to be so qualified, individually or in the aggregate, would be<br \/>\n     reasonably likely to have a material adverse effect on the business,<br \/>\n     properties, financial condition, results of operations or prospects of the<br \/>\n     Company and its Subsidiaries, taken as a whole, or to have a material<br \/>\n     adverse effect on the ability of the Company to consummate the transactions<br \/>\n     contemplated by this Agreement, the Stockholder Agreement or the Company<br \/>\n     Stock Option Agreement other than any effect (a) resulting from or arising<br \/>\n     out of the public announcement of this Agreement or any of the transactions<br \/>\n     contemplated hereby, (b) attributable to any legal action or proceeding<br \/>\n     brought by or on behalf of stockholders of the Company alleging that the<br \/>\n     Board of Directors of the Company breached its fiduciary duties in<br \/>\n     connection with its approval of the Merger, this Agreement or the<br \/>\n     transactions contemplated hereby, or (c) arising or resulting from general<br \/>\n     industry, economic or stock market conditions that affect the Company in a<br \/>\n     manner not disproportionate to the manner in which such conditions affect<br \/>\n     other companies in the technology sector (a &#8220;Company Material Adverse<br \/>\n     Effect&#8221;).<\/p>\n<p>(b)  Except as set forth in the Company SEC Reports (as defined in Section 3.4)<br \/>\n     filed prior to the date of this Agreement, neither the Company nor any of<br \/>\n     its Subsidiaries directly or indirectly owns any equity, membership,<br \/>\n     partnership or similar interest in, or any interest convertible into or<br \/>\n     exchangeable or exercisable for any equity, membership, partnership or<br \/>\n     similar interest in, any corporation, partnership, joint venture, limited<br \/>\n     liability company or other business association or entity, whether<br \/>\n     incorporated or unincorporated.  As used in this Agreement, the word<br \/>\n     &#8220;Subsidiary&#8221; means, with respect to a party, any corporation, partnership,<br \/>\n     joint venture, limited liability company or other business association or<br \/>\n     entity, whether incorporated or unincorporated, of which (i) such party or<br \/>\n     any other Subsidiary of such party is a general partner (excluding<br \/>\n     partnerships, the general partnership interests of which held by such party<br \/>\n     and\/or one or more of its Subsidiaries do not have a majority of the voting<br \/>\n     interest in such partnership), (ii) such party and\/or one or more of its<br \/>\n     Subsidiaries holds voting power to elect a majority of the board of<br \/>\n     directors or other governing body performing similar functions, or (iii)<br \/>\n     such party and\/or one or more of its Subsidiaries, directly or indirectly,<br \/>\n     owns or controls more than 50% of the equity, membership, partnership or<br \/>\n     similar interests.<\/p>\n<p>(c)  The Company has delivered or made available to the Buyer complete and<br \/>\n     accurate copies of the Certificate of Incorporation and By-laws of the<br \/>\n     Company and of the charter, by-laws or other organizational documents of<br \/>\n     each Subsidiary of the Company.<\/p>\n<p>3.2  Capitalization.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n(a)  The authorized capital stock of the Company consists of 20,000,000 shares<br \/>\n     of Company Common Stock and 5,000,000 shares of preferred stock, $.001 par<br \/>\n     value per share (&#8220;Company Preferred Stock&#8221;).  As of the close of business<br \/>\n     on February 7, <\/p>\n<p>                                       8<\/p>\n<p>     2000, (i) 11,584,126 shares of Company Common Stock were issued and<br \/>\n     outstanding, (ii) no shares of Company Common Stock were held in the<br \/>\n     treasury of the Company or by Subsidiaries of the Company, and (iii) no<br \/>\n     shares of the Company Preferred Stock were issued and outstanding.<\/p>\n<p>(b)  Section 3.2(b) of the Company Disclosure Schedule lists the number of<br \/>\n     shares of Company Common Stock reserved for future issuance pursuant to<br \/>\n     stock options granted and outstanding as of the date of this Agreement and<br \/>\n     the plans (if any) under which such options were granted (collectively, the<br \/>\n     &#8220;Company Stock Plans&#8221;) and sets forth a complete and accurate list of all<br \/>\n     holders of outstanding options to purchase shares of Company Common Stock<br \/>\n     (such outstanding options, the &#8220;Company Stock Options&#8221;), indicating the<br \/>\n     number of shares of Company Common Stock subject to each Company Stock<br \/>\n     Option, and the exercise price, the date of grant, vesting schedule and the<br \/>\n     expiration date thereof.  Section 3.2 of the Company Disclosure Schedule<br \/>\n     shows the number of shares of Company Common Stock reserved for future<br \/>\n     issuance pursuant to warrants or other outstanding rights to purchase<br \/>\n     shares of Company Common Stock outstanding as of the date of this Agreement<br \/>\n     (such outstanding warrants or other rights, the &#8220;Company Warrants&#8221;) and the<br \/>\n     agreement or other document under which such Company Warrants were granted<br \/>\n     and sets forth a complete and accurate list of all holders of Company<br \/>\n     Warrants indicating the number and type of shares of Company Common Stock<br \/>\n     subject to each Company Warrant, and the exercise price, the date of grant<br \/>\n     and the expiration date thereof.  Except (x) as set forth in this Section<br \/>\n     3.2 and (y) as reserved for future grants under Company Stock Plans,<br \/>\n     (i) there are no equity securities of any class of the Company or any of<br \/>\n     its Subsidiaries, or any security exchangeable into or exercisable for such<br \/>\n     equity securities, issued, reserved for issuance or outstanding and<br \/>\n     (ii) there are no options, warrants, equity securities, calls, rights,<br \/>\n     commitments or agreements of any character to which the Company or any of<br \/>\n     its Subsidiaries is a party or by which the Company or any of its<br \/>\n     Subsidiaries is bound obligating the Company or any of its Subsidiaries to<br \/>\n     issue, transfer, deliver or sell, or cause to be issued, transferred,<br \/>\n     delivered or sold, additional shares of capital stock of the Company or any<br \/>\n     of its Subsidiaries or any security or rights convertible into or<br \/>\n     exchangeable or exercisable for any such shares, or obligating the Company<br \/>\n     or any of its Subsidiaries to grant, extend, accelerate the vesting of,<br \/>\n     otherwise modify or amend or enter into any such option, warrant, equity<br \/>\n     security, call, right, commitment or agreement. Neither the Company nor any<br \/>\n     of its Subsidiaries has issued and outstanding any stock appreciation<br \/>\n     rights, phantom stock, performance based rights or similar rights or<br \/>\n     obligations. To the knowledge of the Company, other than the Stockholder<br \/>\n     Agreements, there are no agreements or understandings with respect to the<br \/>\n     voting (including voting trusts and proxies) or sale or transfer (including<br \/>\n     agreements imposing transfer restrictions) of any shares of capital stock<br \/>\n     of the Company or any of its Subsidiaries.<\/p>\n<p>                                       9<\/p>\n<p>(c)  All outstanding shares of Company Common Stock are, and all shares of<br \/>\n     Company Common Stock subject to issuance as specified above, upon issuance<br \/>\n     on the terms and conditions specified in the instruments pursuant to which<br \/>\n     they are issuable, will be, duly authorized, validly issued, fully paid and<br \/>\n     nonassessable and not subject to or issued in violation of any purchase<br \/>\n     option, call option, right of first refusal, preemptive right, subscription<br \/>\n     right or any similar right under any provision of the DGCL, the Company&#8217;s<br \/>\n     Certificate of Incorporation or By-laws or any agreement to which the<br \/>\n     Company is a party or is otherwise bound.  There are no obligations,<br \/>\n     contingent or otherwise, of the Company or any of its Subsidiaries to<br \/>\n     repurchase, redeem or otherwise acquire any shares of the Company Common<br \/>\n     Stock or the capital stock of the Company or any of its Subsidiaries or to<br \/>\n     provide funds to or make any material investment (in the form of a loan,<br \/>\n     capital contribution or otherwise) in the Company or any Subsidiary of the<br \/>\n     Company or any other entity, other than guarantees of bank obligations of<br \/>\n     Subsidiaries of the Company entered into in the ordinary course of<br \/>\n     business.<\/p>\n<p>(d)  All of the outstanding shares of capital stock of each of the Company&#8217;s<br \/>\n     Subsidiaries are duly authorized, validly issued, fully paid, nonassessable<br \/>\n     and free of preemptive rights and all such shares (other than directors&#8217;<br \/>\n     qualifying shares in the case of non-U.S. Subsidiaries, all of which the<br \/>\n     Company has the power to cause to be transferred for no or nominal<br \/>\n     consideration to the Buyer or the Buyer&#8217;s designee) are owned, of record<br \/>\n     and beneficially, by the Company or another Subsidiary of the Company free<br \/>\n     and clear of all security interests, liens, claims, pledges, agreements,<br \/>\n     limitations in the Company&#8217;s voting rights, charges or other encumbrances<br \/>\n     of any nature.<\/p>\n<p>(e)  No consent of the holders of Company Stock Options is required in<br \/>\n     connection with the conversion of such options contemplated by Section<br \/>\n     6.11.<\/p>\n<p>3.3  Authority; No Conflict; Required Filings and Consents.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  The Company has all requisite corporate power and authority to enter into<br \/>\n     this Agreement and to consummate the transactions contemplated by this<br \/>\n     Agreement.  The execution and delivery of this Agreement and the<br \/>\n     consummation of the transactions contemplated by this Agreement by the<br \/>\n     Company have been duly authorized by all necessary corporate action on the<br \/>\n     part of the Company, subject only to the approval of the Merger by the<br \/>\n     Company&#8217;s stockholders under the DGCL.  This Agreement has been duly<br \/>\n     executed and delivered by the Company and constitutes valid and binding<br \/>\n     obligation of the Company, enforceable in accordance with its terms.<\/p>\n<p>(b)  Except as disclosed in Section 3.3(b) of the Company Disclosure Schedule,<br \/>\n     the execution and delivery of this Agreement by the Company does not, and<br \/>\n     the consummation of the transactions contemplated by this Agreement will<br \/>\n     not, (i) conflict with, or result in any violation or breach of, any<br \/>\n     provision of the Certificate <\/p>\n<p>                                       10<\/p>\n<p>     of Incorporation or By-laws of the Company or the charter, by-laws, or<br \/>\n     other organizational document of any Subsidiary of the Company, (ii)<br \/>\n     conflict with, or result in any violation or breach of, or constitute (with<br \/>\n     or without notice or lapse of time, or both) a default (or give rise to a<br \/>\n     right of termination, cancellation or acceleration of any obligation or<br \/>\n     loss of any material benefit) under, or require a consent or waiver under,<br \/>\n     any of the terms, conditions or provisions of any note, bond, mortgage,<br \/>\n     indenture, lease, license, contract or other agreement, instrument or<br \/>\n     obligation to which the Company or any of its Subsidiaries is a party or by<br \/>\n     which any of them or any of their properties or assets may be bound, or<br \/>\n     (iii) subject to compliance with the requirements specified in clauses (i),<br \/>\n     (ii), (iii), (iv) and (v) of Section 3.3(c), conflict with or violate any<br \/>\n     permit, concession, franchise, license, judgment, injunction, order,<br \/>\n     decree, statute, law, ordinance, rule or regulation applicable to the<br \/>\n     Company or any of its Subsidiaries or any of its or their properties or<br \/>\n     assets, except in the case of clauses (ii) and (iii) of this Section 3.3(b)<br \/>\n     for any such conflicts, violations, breaches, defaults, terminations,<br \/>\n     cancellations, accelerations or losses which, individually or in the<br \/>\n     aggregate, are not reasonably likely to have a Company Material Adverse<br \/>\n     Effect.<\/p>\n<p>(c)  No consent, approval, license, permit, order or authorization of, or,<br \/>\n     registration, declaration, notice or filing with, any court, arbitrational<br \/>\n     tribunal, administrative agency or commission or other governmental or<br \/>\n     regulatory authority or agency (a &#8220;Governmental Entity&#8221;) is required by or<br \/>\n     with respect to the Company or any of its Subsidiaries in connection with<br \/>\n     the execution and delivery of this Agreement by the Company or the<br \/>\n     consummation of the transactions contemplated by this Agreement, except for<br \/>\n     (i) the filing of a pre-merger notification report under the Hart-Scott-<br \/>\n     Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;HSR Act&#8221;),<br \/>\n     (ii) the filing of the Certificate of Merger with the Delaware Secretary of<br \/>\n     State, (iii) the filing of the Proxy Statement (as defined in Section 3.16<br \/>\n     below) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) in<br \/>\n     accordance with the Securities Exchange Act of 1934, as amended (the<br \/>\n     &#8220;Exchange Act&#8221;), (iv) the filing of such reports or schedules under Section<br \/>\n     13 of the Exchange Act as may be required in connection with this Agreement<br \/>\n     and the transactions contemplated hereby and (v) such consents, approvals,<br \/>\n     orders, authorizations, registrations, declarations and filings as may be<br \/>\n     required under applicable state securities laws except where the failure to<br \/>\n     obtain any such consent, approval, order, authorization, registration,<br \/>\n     declaration or filing would not have a Company Material Adverse Effect.<\/p>\n<p>(d)  The affirmative vote of the holders of a majority of the outstanding shares<br \/>\n     of Company Common Stock on the record date for the Company Meeting (as<br \/>\n     defined below) is the only vote of the holders of any class or series of<br \/>\n     the Company&#8217;s capital stock or other securities necessary to adopt this<br \/>\n     Agreement.  There are no bonds, debentures, notes or other indebtedness of<br \/>\n     the Company having the right to vote (or convertible into, or exchangeable<br \/>\n     for, securities having the right to vote) on any matters on which<br \/>\n     stockholders of the Company may vote.<\/p>\n<p>                                       11<\/p>\n<p>3.4  SEC Filings; Financial Statements.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  The Company has filed and made available to the Buyer all forms, reports<br \/>\n     and other documents required to be filed by the Company with the SEC since<br \/>\n     its inception.  All such required forms, reports and other documents<br \/>\n     (including those that the Company may file after the date hereof until the<br \/>\n     Closing) together with any amendments thereto are referred to herein as the<br \/>\n     &#8220;Company SEC Reports.&#8221;  The Company SEC Reports (i) were or will be filed<br \/>\n     on a timely basis, (ii) were or will be prepared in compliance in all<br \/>\n     material respects with the applicable requirements of the Securities Act of<br \/>\n     1933, as amended (the &#8220;Securities Act&#8221;), and the Exchange Act, as the case<br \/>\n     may be, and the rules and regulations of the SEC thereunder applicable to<br \/>\n     such Company SEC Reports, and (iii) did not or will not at the time they<br \/>\n     were or are filed contain any untrue statement of a material fact or omit<br \/>\n     to state a material fact required to be stated in such Company SEC Reports<br \/>\n     or necessary in order to make the statements in such Company SEC Reports,<br \/>\n     in the light of the circumstances under which they were made, not<br \/>\n     misleading.  No Subsidiary of the Company is required to file any forms,<br \/>\n     reports or other documents with the SEC.<\/p>\n<p>(b)  Each of the consolidated financial statements (including, in each case, any<br \/>\n     related notes and schedules) contained or to be contained in the Company<br \/>\n     SEC Reports (i) complied or will comply as to form in all material respects<br \/>\n     with applicable accounting requirements and the published rules and<br \/>\n     regulations of the SEC with respect thereto, (ii) were or will be prepared<br \/>\n     in accordance with United States generally accepted accounting principles<br \/>\n     applied on a consistent basis throughout the periods involved (except as<br \/>\n     may be indicated in the notes to such financial statements or, in the case<br \/>\n     of unaudited statements, as permitted by the SEC on Form 10-Q under the<br \/>\n     Exchange Act) and (iii) fairly presented or will fairly present the<br \/>\n     consolidated financial position of the Company and its Subsidiaries as of<br \/>\n     the dates thereof and the consolidated results of their operations and cash<br \/>\n     flows for the periods indicated, consistent with the books and records of<br \/>\n     the Company and its Subsidiaries, except that the unaudited interim<br \/>\n     financial statements were or are subject to normal and recurring year-end<br \/>\n     adjustments which were not or are not expected to be material in amount.<br \/>\n     The unaudited balance sheet of the Company as of September 30, 1999 is<br \/>\n     referred to herein as the &#8220;Company Balance Sheet.&#8221;<\/p>\n<p>3.5  No Undisclosed Liabilities.  Except as disclosed in the Company SEC Reports<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nfiled prior to the date of this Agreement, and except for normal or recurring<br \/>\nliabilities incurred since the date of the Company Balance Sheet in the ordinary<br \/>\ncourse of business consistent with past practices, the Company and its<br \/>\nSubsidiaries do not have any liabilities, either accrued, contingent or<br \/>\notherwise (whether or not required to be reflected in financial statements in<br \/>\naccordance with United States generally accepted accounting principles), and<br \/>\nwhether due or to become due, which, individually or in the aggregate, are<br \/>\nreasonably likely to have a Company Material Adverse Effect.<\/p>\n<p>                                       12<\/p>\n<p>3.6  Absence of Certain Changes or Events.  Except as disclosed in the Company<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSEC Reports filed prior to the date of this Agreement, since the date of the<br \/>\nCompany Balance Sheet, the Company and its Subsidiaries have conducted their<br \/>\nrespective businesses only in the ordinary course and in a manner consistent<br \/>\nwith past practice and, since such date, there has not been (i) any event,<br \/>\nchange or development in the business, properties, financial condition, results<br \/>\nof operations or prospects of the Company and its Subsidiaries, taken as a<br \/>\nwhole, which, individually or in the aggregate, has had, or is reasonably likely<br \/>\nto have, a Company Material Adverse Effect; or (ii) except as disclosed pursuant<br \/>\nto this Agreement (including Section 3.6 of the Company Disclosure Schedule) any<br \/>\nother action or event that would have required the consent of the Buyer pursuant<br \/>\nto Section 5.1 of this Agreement had such action or event occurred after the<br \/>\ndate of this Agreement.<\/p>\n<p>3.7  Taxes.<br \/>\n     &#8212;&#8211; <\/p>\n<p>(a)  The Company and each of its Subsidiaries has filed all Tax Returns (as<br \/>\n     defined below) that it was required to file, and all such Tax Returns were<br \/>\n     correct and complete except for any errors or omissions which are not,<br \/>\n     individually or in the aggregate, reasonably likely to have a Company<br \/>\n     Material Adverse Effect.  To the knowledge of the Company, each group of<br \/>\n     corporations with which the Company or any Subsidiary has filed (or was<br \/>\n     required to file) consolidated, combined, unitary or similar Tax Returns<br \/>\n     (an &#8220;Affiliated Group&#8221;) has filed all Tax Returns that it was required to<br \/>\n     file with respect to any period in which the Company or a Subsidiary was a<br \/>\n     member of such Affiliated Group (an &#8220;Affiliated Period&#8221;), and all such Tax<br \/>\n     Returns were correct and complete except for any errors or omissions which<br \/>\n     are not, individually or in the aggregate, reasonably likely to have a<br \/>\n     Company Material Adverse Effect.  The Company and each of its Subsidiaries<br \/>\n     has paid on a timely basis all Taxes (as defined below) that are shown to<br \/>\n     be due on any such Tax Returns and to the knowledge of the Company each<br \/>\n     Affiliated Group has paid all that were due and payable with respect to all<br \/>\n     Affiliated Periods.  The unpaid Taxes of the Company and its Subsidiaries<br \/>\n     for Tax periods through the date of the Company Balance Sheet do not exceed<br \/>\n     the accruals and reserves for Taxes set forth on the Company Balance Sheet<br \/>\n     exclusive of any accruals and reserves for &#8220;deferred taxes&#8221; or similar<br \/>\n     items that reflect timing differences between Tax and financial accounting<br \/>\n     principles.  All Taxes that the Company or any of its Subsidiaries is or<br \/>\n     was required by law to withhold or collect have been duly withheld or<br \/>\n     collected and, to the extent required, have been paid to the proper<br \/>\n     Governmental Entity.  For purposes of this Agreement, (i) &#8220;Taxes&#8221; means all<br \/>\n     taxes, charges, fees, levies or other similar assessments or liabilities,<br \/>\n     including income, gross receipts, ad valorem, premium, value-added, excise,<br \/>\n     real property, personal property, sales, use, services, transfer,<br \/>\n     withholding, employment, payroll and franchise taxes imposed by the United<br \/>\n     States of America or any state, local or foreign government, or any agency<br \/>\n     thereof, or other political subdivision of the United States or any such<br \/>\n     government, and any interest, fines, penalties, assessments or additions to<br \/>\n     tax resulting from, attributable to <\/p>\n<p>                                       13<\/p>\n<p>     or incurred in connection with any tax or any contest or dispute thereof<br \/>\n     and (ii) &#8220;Tax Returns&#8221; means all reports, returns, declarations, statements<br \/>\n     or other information required to be supplied to a taxing authority in<br \/>\n     connection with Taxes.<\/p>\n<p>(b)  The Company has delivered to the Buyer correct and complete copies of all<br \/>\n     federal income Tax Returns, examination reports and statements of<br \/>\n     deficiencies assessed against or agreed to by the Company or any of its<br \/>\n     Subsidiaries since inception to the knowledge of the Company and correct<br \/>\n     and complete copies of the portion of the federal income Tax Returns,<br \/>\n     examination reports and statements of deficiency assessed against or agreed<br \/>\n     to with respect to any Affiliated Group relating to the activities of the<br \/>\n     Company and the Subsidiaries for all Affiliated Periods.  The federal<br \/>\n     income Tax Returns of the Company and each of its Subsidiaries and to the<br \/>\n     knowledge of the Company each Affiliated Group have been audited by the<br \/>\n     Internal Revenue Service or are closed by the applicable statute of<br \/>\n     limitations for all taxable years through the taxable year specified in<br \/>\n     Section 3.7(b) of the Company Disclosure Schedule.  The Company has made<br \/>\n     available to the Buyer correct and complete copies of all other Tax Returns<br \/>\n     of the Company and its Subsidiaries together with all related examination<br \/>\n     reports and statements of deficiency for all periods and to the knowledge<br \/>\n     of the Company correct and complete copies of the portion of all other Tax<br \/>\n     Returns, examination reports and statements of deficiency assessed against<br \/>\n     or agreed to with respect to any Affiliated Group relating to the<br \/>\n     activities of the Company and the Subsidiaries for all Affiliated Periods.<br \/>\n     No examination or audit of any Tax Return of the Company or any of its<br \/>\n     Subsidiaries or to the knowledge of the Company any Affiliated Group with<br \/>\n     respect to any Affiliated Period by any Governmental Entity is currently in<br \/>\n     progress or, to the knowledge of the Company and its Subsidiaries,<br \/>\n     threatened or contemplated.  Neither the Company nor any of its<br \/>\n     Subsidiaries nor to the knowledge of the Company any member of the<br \/>\n     Affiliated Group has been informed by any Governmental Entity that the<br \/>\n     Governmental Entity believes that the Company or any of its Subsidiaries or<br \/>\n     the Affiliated Group was required to file any Tax Return that was not<br \/>\n     filed.  Neither the Company nor any of its Subsidiaries has waived any<br \/>\n     statute of limitations with respect to Taxes or agreed to an extension of<br \/>\n     time with respect to a Tax assessment or deficiency.<\/p>\n<p>(c)  Neither the Company nor any of its Subsidiaries:  (i) is a &#8220;consenting<br \/>\n     corporation&#8221; within the meaning of Section 341(f) of the Code, and none of<br \/>\n     the assets of the Company or its Subsidiaries are subject to an election<br \/>\n     under Section 341(f) of the Code; (ii) has been a United States real<br \/>\n     property holding corporation within the meaning of Section 897(c)(2) of the<br \/>\n     Code during the applicable period specified in Section 897(c)(l)(A)(ii) of<br \/>\n     the Code; (iii) has made any payments, is obligated to make any payments,<br \/>\n     or is a party to any agreement that could obligate it to make any payments<br \/>\n     that may be treated as an &#8220;excess parachute payment&#8221; under Section 280G of<br \/>\n     the Code; (iv) has any actual or potential liability for any Taxes of any<br \/>\n     person (other than the Company and its Subsidiaries) under Treasury<br \/>\n     Regulation <\/p>\n<p>                                       14<\/p>\n<p>     Section 1.1502-6 (or any similar provision of law in any jurisdiction), or<br \/>\n     as a transferee or successor, by contract, or otherwise; or (v) is or has<br \/>\n     been required to make a basis reduction pursuant to Treasury Regulation<br \/>\n     Section 1.1502-20(b) or Treasury Regulation Section 1.337(d)-2(b).<\/p>\n<p>(d)  None of the assets of the Company or any of its Subsidiaries: (i) is<br \/>\n     property that is required to be treated as being owned by any other person<br \/>\n     pursuant to the provisions of former Section 168(f)(8) of the Code; (ii) is<br \/>\n     &#8220;tax-exempt use property&#8221; within the meaning of Section 168(h) of the Code;<br \/>\n     or (iii) directly or indirectly secures any debt the interest on which is<br \/>\n     tax exempt under Section 103(a) of the Code.<\/p>\n<p>(e)  Neither the Company nor any of its Subsidiaries has undergone, or will<br \/>\n     undergo as a result of the transactions contemplated by the Agreement, a<br \/>\n     change in its method of accounting resulting in an adjustment to its<br \/>\n     taxable income pursuant to Section 481(a) of the Code.<\/p>\n<p>(f)  Except as disclosed in Section 3.7(f) of the Company Disclosure Schedule,<br \/>\n     neither the Company nor any of its Subsidiaries (i) is or has ever been a<br \/>\n     member of a group of corporations with which it has filed (or been required<br \/>\n     to file) consolidated, combined or unitary Tax Returns, other than a group<br \/>\n     of which only the Company and its Subsidiaries are or were members or (ii)<br \/>\n     is a party to or bound by any Tax indemnity, Tax sharing or Tax allocation<br \/>\n     agreement.<\/p>\n<p>(g)  No state or federal &#8220;net operating loss&#8221; of the Company determined as of<br \/>\n     the Closing Date is subject to limitation on its use pursuant to Section<br \/>\n     382 of the Code or comparable provisions of state law as a result of any<br \/>\n     &#8220;ownership change&#8221; within the meaning of Section 382(g) of the Code<br \/>\n     occurring prior to the Closing Date.<\/p>\n<p>(h)  Since June 7, 1997 one or more persons have not acquired, directly or<br \/>\n     indirectly, a 50% or greater interest in either the Company, or to the<br \/>\n     knowledge of the Company, Creative Computers Inc. (DE) or Creative<br \/>\n     Computers, Inc. (CA), such interest calculated in the manner required under<br \/>\n     Section 355(e) of the Code.<\/p>\n<p>3.8  Owned and Leased Real Properties.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  The Company does not own and has never owned any real property.<\/p>\n<p>(b)  The Company has provided to the Buyer in Section 3.8(b) of the Company<br \/>\n     Disclosure Schedule a complete and accurate list of all real property<br \/>\n     leased by the Company or its Subsidiaries (collectively &#8220;Company Leases&#8221;)<br \/>\n     and the location of the premises.  The Company is not in default in any<br \/>\n     material respect under any of the Company Leases.  Each of the Company<br \/>\n     Leases is in full force and effect and will not <\/p>\n<p>                                       15<\/p>\n<p>     cease to be in full force and effect as a result of the transactions<br \/>\n     contemplated by this Agreement.<\/p>\n<p>3.9  Intellectual Property.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  The Company and its Subsidiaries exclusively own, or are licensed or<br \/>\n     otherwise possess legally enforceable rights to use, without any obligation<br \/>\n     to make any fixed or contingent payments, including any royalty payments,<br \/>\n     all patents, trademarks, trade names, domain names, service marks and<br \/>\n     copyrights, any applications for and registrations of such patents,<br \/>\n     trademarks, trade names, domain names, service marks and copyrights, and<br \/>\n     all processes, formulae, methods, schematics, technology, know-how,<br \/>\n     computer software programs or applications and tangible or intangible<br \/>\n     proprietary information or material that are used or necessary to conduct<br \/>\n     the business of the Company and its Subsidiaries as currently conducted<br \/>\n     (the &#8220;Company Intellectual Property Rights&#8221;).<\/p>\n<p>(b)  Except as disclosed in Section 3.9(b) in the Company Disclosure Schedule,<br \/>\n     the execution and delivery of this Agreement and consummation of the Merger<br \/>\n     will not result in the breach of, or create on behalf of any third party<br \/>\n     the right to terminate or modify, any material license, sublicense or other<br \/>\n     agreement relating to the Company Intellectual Property Rights, or any<br \/>\n     license, sublicense and other agreement as to which the Company or any of<br \/>\n     its Subsidiaries is a party and pursuant to which the Company or any of its<br \/>\n     Subsidiaries is authorized to use any third party patents, trademarks,<br \/>\n     copyrights or trade secrets (the &#8220;Company Third Party Intellectual Property<br \/>\n     Rights&#8221;), including software that is used in the manufacture of,<br \/>\n     incorporated in, or forms a part of any product or service sold or expected<br \/>\n     to be sold by the Company or any of its Subsidiaries.<\/p>\n<p>(c)  Except as disclosed in Section 3.9 in the Company Disclosure Schedule:<\/p>\n<p>(i)  All issued patents, registered trademarks, registered service marks and<br \/>\n     registered copyrights which are held by the Company or any of its<br \/>\n     Subsidiaries and which are material to the business of the Company and its<br \/>\n     Subsidiaries, taken as a whole, are valid and subsisting.  The Company and<br \/>\n     its Subsidiaries have taken reasonable measures to protect the proprietary<br \/>\n     nature of the Company Intellectual Property Rights that are material to the<br \/>\n     business of the Company and its Subsidiaries, taken as a whole, and to<br \/>\n     maintain in confidence all trade secrets and confidential information owned<br \/>\n     or used by the Company or any of its Subsidiaries and that are material to<br \/>\n     the business of the Company and its Subsidiaries, taken as a whole.<\/p>\n<p>                                       16<\/p>\n<p>(ii) To the knowledge of the Company, no other person or entity is infringing,<br \/>\n     violating or misappropriating any of the Company Intellectual Property<br \/>\n     Rights.<\/p>\n<p>(iii)None of the activities or business previously or currently conducted by<br \/>\n     the Company or any of the Subsidiaries infringes, violates or constitutes a<br \/>\n     misappropriation of, any patents, trademarks, trade names, service marks<br \/>\n     and copyrights, any applications for and registrations of such patents,<br \/>\n     trademarks, trade names, service marks and copyrights, and all processes,<br \/>\n     formulae, methods, schematics, technology, know-how, computer software<br \/>\n     programs or applications and tangible or intangible proprietary information<br \/>\n     or material of any other person or entity except for any infringement,<br \/>\n     violation or misappropriation that would not have a Company Material<br \/>\n     Adverse Effect. Neither the Company nor any of its Subsidiaries has<br \/>\n     received any complaint, claim or notice alleging any such infringement,<br \/>\n     violation or misappropriation.<\/p>\n<p>(d)  Source Code. Except as set forth on Schedule 3.9(d) of the Company<br \/>\n     &#8212;&#8212;&#8212;&#8211;<br \/>\n     Disclosure Schedule, the Company has not disclosed, granted access to,<br \/>\n     permitted use of or otherwise made available its source code relating to<br \/>\n     its Technology Systems to any third party.<\/p>\n<p>3.10  Agreements, Contracts and Commitments.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>(a)  Section 3.10(a) of the Company Disclosure Schedule sets forth a list of all<br \/>\n     contracts, agreements and commitments, written or oral (&#8220;Contracts&#8221;), of<br \/>\n     the following categories to which the Company or any of its Subsidiaries is<br \/>\n     a party or by which any of them is bound (&#8220;Company Material Contracts&#8221;):<\/p>\n<p>(i)  Contracts under which the Company or any Subsidiary licenses any Company<br \/>\n     Intellectual Property Rights to a third party, other than to customers in<br \/>\n     the ordinary course of business;<\/p>\n<p>(ii) Contracts under which the Company or any Subsidiary licenses any material<br \/>\n     item of intellectual property from a third party;<\/p>\n<p>(iii)Contracts with any Affiliate of the Company;<\/p>\n<p>(iv) Contracts for the acquisition, sale or disposition of any material assets<br \/>\n     of the Company or any of its Subsidiaries outside the ordinary course of<br \/>\n     business;<\/p>\n<p>(v)  any Contract not disclosed in a Company SEC Report that is a material<br \/>\n     contract (as defined in Item 601(b)(10) of Regulation S-K of the SEC);<\/p>\n<p>                                       17<\/p>\n<p>(vi)   any Contract under which a third party would be entitled to receive a<br \/>\n       license or any other right to intellectual property of the Buyer or any<br \/>\n       of Buyer&#8217;s affiliates (as defined in Rule 405 under the Securities Act),<br \/>\n       other than the Surviving Corporation, following the Closing, and<\/p>\n<p>(vii)  any Contract that would require Buyer to register any shares of Buyer<br \/>\n       Common Stock under the Securities Act after the Closing<\/p>\n<p>(viii) any Contract with America Online, Inc.<\/p>\n<p>(b)  Except as disclosed in Section 3.10(b) in the Company Disclosure Schedule,<br \/>\n     each Company Material Contract has not expired by its terms and is in full<br \/>\n     force and effect.  Neither the Company nor any of its Subsidiaries is in<br \/>\n     violation of or in default under (nor does there exist any condition which,<br \/>\n     upon the passage of time or the giving of notice or both, would cause such<br \/>\n     a violation of or default under) any Company Material Contract or any other<br \/>\n     loan or credit agreement, note, bond, mortgage, indenture, lease, permit,<br \/>\n     concession, franchise, license or other contract, arrangement or<br \/>\n     understanding to which it is a party or by which it or any of its<br \/>\n     properties or assets is bound, except for violations or defaults which,<br \/>\n     individually or in the aggregate, have not resulted in, and are not<br \/>\n     reasonably likely to result in, a Company Material Adverse Effect.<\/p>\n<p>3.11 Litigation.  Except as disclosed in the Company SEC Reports filed prior to<br \/>\n     &#8212;&#8212;&#8212;-<br \/>\nthe date of this Agreement and in Section 3.11 in the Company Disclosure<br \/>\nSchedule, there is no action, suit, proceeding, claim, arbitration or<br \/>\ninvestigation pending or, to the knowledge of the Company, threatened against or<br \/>\naffecting the Company or any of its Subsidiaries which, individually or in the<br \/>\naggregate, has had, or is reasonably likely to have, a Company Material Adverse<br \/>\nEffect.  There are no judgments, orders or decrees outstanding against the<br \/>\nCompany.<\/p>\n<p>3.12  Environmental Matters.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  Except as disclosed in the Company SEC Reports filed prior to the date of<br \/>\n     this Agreement and except for such matters which, individually or in the<br \/>\n     aggregate, have not had, and are not reasonably likely to have a Company<br \/>\n     Material Adverse Effect: (i) the Company and each of its Subsidiaries has<br \/>\n     complied with, and is not in violation of, any applicable Environmental<br \/>\n     Laws (as defined in Section 3.12(b)); (ii) the properties currently owned<br \/>\n     or operated by the Company and its Subsidiaries (including soils,<br \/>\n     groundwater, surface water, buildings or other structures) are not<br \/>\n     contaminated with any Hazardous Substances (as defined in Section 3.12(c));<br \/>\n     (iii) the properties formerly owned or operated by the Company or any of<br \/>\n     its Subsidiaries were not contaminated with Hazardous Substances prior to<br \/>\n     or during the period of ownership or operation by the Company or any of its<br \/>\n     Subsidiaries; (iv) neither the Company nor its Subsidiaries are subject to<br \/>\n     liability for any Hazardous Substance <\/p>\n<p>                                       18<\/p>\n<p>     disposal or contamination on the property of any third party; (v) neither<br \/>\n     the Company nor any of its Subsidiaries have released any Hazardous<br \/>\n     Substance to the environment; (vi) neither the Company nor any of its<br \/>\n     Subsidiaries has received any notice, demand, letter, claim or request for<br \/>\n     information alleging that the Company or any of its Subsidiaries may be in<br \/>\n     violation of, liable under or have obligations under any Environmental Law;<br \/>\n     (vii) neither the Company nor any of its Subsidiaries is subject to any<br \/>\n     orders, decrees, injunctions or other arrangements with any Governmental<br \/>\n     Entity or is subject to any indemnity or other agreement with any third<br \/>\n     party relating to liability under any Environmental Law or relating to<br \/>\n     Hazardous Substances; and (viii) there are no circumstances or conditions<br \/>\n     involving the Company or any of its Subsidiaries that could reasonably be<br \/>\n     expected to result in any claims, liability, obligations, investigations,<br \/>\n     costs or restrictions on the ownership, use or transfer of any property of<br \/>\n     the Company or any of its Subsidiaries pursuant to any Environmental Law.<\/p>\n<p>(b)  For purposes of this Agreement, &#8220;Environmental Law&#8221; means any law,<br \/>\n     regulation, order, decree, permit, authorization, opinion, common law or<br \/>\n     agency requirement of any jurisdiction relating to: (A) the protection,<br \/>\n     investigation or restoration of the environment, human health and safety,<br \/>\n     or natural resources, (B) the handling, use, presence, disposal, release or<br \/>\n     threatened release of any Hazardous Substance or (C) noise, odor, wetlands,<br \/>\n     pollution, contamination or any injury or threat of injury to persons or<br \/>\n     property.<\/p>\n<p>(c)  For purposes of this Agreement, &#8220;Hazardous Substance&#8221; means any substance<br \/>\n     that is: (A) listed, classified, regulated or which falls within the<br \/>\n     definition of a &#8220;hazardous substance&#8221; or &#8220;hazardous material&#8221; pursuant to<br \/>\n     any Environmental Law; (B) any petroleum product or by-product, asbestos-<br \/>\n     containing material, lead-containing paint or plumbing, polychlorinated<br \/>\n     biphenyls, radioactive materials or radon; or (C) any other substance which<br \/>\n     is the subject of regulatory action by any Governmental Entity pursuant to<br \/>\n     any Environmental Law.<\/p>\n<p>(d)  Section 3.12(d) of the Company Disclosure Schedule sets forth a complete<br \/>\n     and accurate list of all documents (whether in hard copy or electronic<br \/>\n     form) that contain any environmental reports, investigations and audits<br \/>\n     relating to premises currently or previously owned or operated by the<br \/>\n     Company or any of its Subsidiaries (whether conducted by or on behalf of<br \/>\n     the Company or one of its Subsidiaries or a third party, and whether done<br \/>\n     at the initiative of the Company or one of its Subsidiaries or directed by<br \/>\n     a Governmental Entity or other third party) which were issued or conducted<br \/>\n     during the past five years and of which the Company has possession.  A<br \/>\n     complete and accurate copy of each such document has been provided to the<br \/>\n     Buyer.<\/p>\n<p>3.13  Employee Benefit Plans.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;- <\/p>\n<p>(a)  Section 3.13(a) of the Company Disclosure Schedule sets forth a complete<br \/>\n     and accurate list of all Employee Benefit Plans (as defined below)<br \/>\n     maintained, <\/p>\n<p>                                       19<\/p>\n<p>     or contributed to, by the Company, any Subsidiary of the Company, or any<br \/>\n     ERISA Affiliate (as defined below) with respect to which the Company or any<br \/>\n     Subsidiary has or may have any actual or contingent liabilities (together,<br \/>\n     the &#8220;Company Employee Plans&#8221;). For purposes of this Agreement, the<br \/>\n     following terms shall have the following meanings: (i) &#8220;Employee Benefit<br \/>\n     Plan&#8221; means any &#8220;employee pension benefit plan&#8221; (as defined in Section 3(2)<br \/>\n     of ERISA), any &#8220;employee welfare benefit plan&#8221; (as defined in Section 3(1)<br \/>\n     of ERISA), and any other plan, agreement or arrangement involving direct or<br \/>\n     indirect compensation or fringe benefits, including without limitation<br \/>\n     insurance coverage, severance benefits, disability benefits, deferred<br \/>\n     compensation, bonuses, stock options, stock purchase, phantom stock, stock<br \/>\n     appreciation or other forms of incentive compensation or post-retirement<br \/>\n     compensation; (ii) &#8220;ERISA&#8221; means the Employee Retirement Income Security<br \/>\n     Act of 1974, as amended; and (iii) &#8220;ERISA Affiliate&#8221; means any entity which<br \/>\n     is, or at any applicable time was, a member of (1) a controlled group of<br \/>\n     corporations (as defined in Section 414(b) of the Code), (2) a group of<br \/>\n     trades or businesses under common control (as defined in Section 414(c) of<br \/>\n     the Code), or (3) an affiliated service group (as defined under Section<br \/>\n     414(m) of the Code or the regulations under Section 414(o) of the Code),<br \/>\n     any of which includes or included the Company or a Subsidiary.<\/p>\n<p>(b)  With respect to each Company Employee Plan, the Company has furnished to<br \/>\n     the Buyer, a complete and accurate copy of (i) such Company Employee Plan<br \/>\n     (or a written summary of any unwritten plan), (ii) the most recent annual<br \/>\n     report (Form 5500, 5500C or 5500R) filed with the IRS, if any, required<br \/>\n     under ERISA or the Code, (iii) each trust agreement, group annuity contract<br \/>\n     and summary plan description, if any, required under ERISA relating to such<br \/>\n     Company Employee Plan and (iv) reports, if any, regarding the satisfaction<br \/>\n     of the nondiscrimination requirements of Sections 401(a)(4), 401(k), 401(m)<br \/>\n     and 410(b) of the Code for the last plan year for which such tests has been<br \/>\n     performed.<\/p>\n<p>(c)  Each Company Employee Plan has been administered in all material respects<br \/>\n     in accordance with its terms and each of the Company, the Company&#8217;s<br \/>\n     Subsidiaries and their ERISA Affiliates has in all material respects met<br \/>\n     its obligations with respect to such Company Employee Plan and has made all<br \/>\n     required contributions thereto.  With respect to the Company Employee<br \/>\n     Plans, no event has occurred, and to the knowledge of the Company, there<br \/>\n     exists no condition or set of circumstances in connection with which the<br \/>\n     Company or any of its Subsidiaries could be subject to (i) any liability<br \/>\n     (other than the obligation to fund and administer the plans in accordance<br \/>\n     with their respective terms) under ERISA, the Code or any other applicable<br \/>\n     law which, individually or in the aggregate, is reasonably likely to have a<br \/>\n     Company Material Adverse Effect; or (ii) any contractual indemnification or<br \/>\n     contribution obligation protecting any fiduciary, insurer or service<br \/>\n     provider with respect to any Company Employee Plan.<\/p>\n<p>                                       20<\/p>\n<p>(d)  With respect to the Company Employee Plans, there are no funded benefit<br \/>\n     obligations for which contributions have not been made or properly accrued<br \/>\n     and there are no unfunded benefit obligations (other than routine claims<br \/>\n     for benefits) which have not been accounted for by reserves, or otherwise<br \/>\n     properly footnoted in accordance with United States generally accepted<br \/>\n     accounting principles, on the financial statements of the Company.<\/p>\n<p>(e)  All the Company Employee Plans that are intended to be qualified under<br \/>\n     Section 401(a) of the Code have received determination letters from the<br \/>\n     Internal Revenue Service to the effect that such Company Employee Plans are<br \/>\n     qualified and the plans and trusts related thereto are exempt from federal<br \/>\n     income taxes under Sections 401(a) and 501(a), respectively, of the Code,<br \/>\n     or were established using a standardized prototype plan document with<br \/>\n     respect to which a determination letter was received by the sponsor, no<br \/>\n     such determination letter has been revoked and revocation has not been<br \/>\n     threatened, and no such Company Employee Plan has been amended or operated<br \/>\n     since the date of its most recent determination letter or application<br \/>\n     therefor in any respect, and no act or omission has occurred, that would<br \/>\n     adversely affect its qualification or materially increase its cost.<\/p>\n<p>(f)  Neither the Company, any Subsidiary of the Company nor any ERISA Affiliate<br \/>\n     has (i) ever maintained a Company Employee Plan which was ever subject to<br \/>\n     Section 412 of the Code or Title IV of ERISA or (ii) ever been obligated to<br \/>\n     contribute to, or otherwise has any liability with respect to, a<br \/>\n     &#8220;multiemployer plan&#8221; (as defined in Section 4001(a)(3) of ERISA).  No<br \/>\n     Company Employee Plan is funded by, associated with or related to a<br \/>\n     &#8220;voluntary employee&#8217;s beneficiary association&#8221; within the meaning of<br \/>\n     Section 501(c)(9) of the Code.<\/p>\n<p>(g)  Each Company Employee Plan is amendable and terminable unilaterally by the<br \/>\n     Company at any time without any material liability to the Company as a<br \/>\n     result thereof and no Company Employee Plan, plan documentation or<br \/>\n     agreement, summary plan description or other written communication<br \/>\n     distributed generally to employees by its terms prohibits the Company from<br \/>\n     amending or terminating any such Company Employee Plan.<\/p>\n<p>(h)  Except for plans identified in Section 3.13(a) or in Section 3.10(h) of the<br \/>\n     Company Disclosure Schedule or the Company SEC Reports filed prior to the<br \/>\n     date of this Agreement, neither the Company nor any of its Subsidiaries is<br \/>\n     a party to any (i) agreement with any stockholders, director, executive<br \/>\n     officer or other key employee of the Company or any of its Subsidiaries<br \/>\n     (A) the benefits of which are contingent, or the terms of which are<br \/>\n     materially altered, upon the occurrence of a transaction involving the<br \/>\n     Company or any of its Subsidiaries of the nature of any of the transactions<br \/>\n     contemplated by this Agreement, (B) providing any term of employment or<br \/>\n     compensation guarantee or (C) providing severance benefits or other<br \/>\n     benefits after the termination of employment of such director, executive<br \/>\n     officer or key employee; <\/p>\n<p>                                       21<\/p>\n<p>     (ii) agreement, plan or arrangement under which any person may receive<br \/>\n     payments from the Company or any of its Subsidiaries that may be subject to<br \/>\n     the tax imposed by Section 4999 of the Code or included in the<br \/>\n     determination of such person&#8217;s &#8220;parachute payment&#8221; under Section 280G of<br \/>\n     the Code; and (iii) agreement or plan binding the Company or any of its<br \/>\n     Subsidiaries, including any stock option plan, stock appreciation right<br \/>\n     plan, restricted stock plan, stock purchase plan, severance benefit plan,<br \/>\n     or Company Employee Plan, any of the benefits of which will be increased,<br \/>\n     or the vesting of the benefits of which will be accelerated, by the<br \/>\n     occurrence of any of the transactions contemplated by this Agreement or the<br \/>\n     value of any of the benefits of which will be calculated on the basis of<br \/>\n     any of the transactions contemplated by this Agreement.<\/p>\n<p>(i)  Except as disclosed in Section 3.13(i) of the Company Disclosure Schedule:<br \/>\n     (i) no claims (other than claims for benefits payable in the normal<br \/>\n     operation of the Company Employee Plans) are outstanding with respect to<br \/>\n     any Company Employee Plan; (ii) there are no pending nor, to the Company&#8217;s<br \/>\n     knowledge, threatened legal proceedings with respect to any Company<br \/>\n     Employee Plan; and (iii) no Company Employee Plan is the subject of an<br \/>\n     examination by any governmental authority or of any government-sponsored<br \/>\n     amnesty, voluntary compliance or similar program.<\/p>\n<p>(j)  The Company represents that it has or will have immediately prior to the<br \/>\n     Effective Time all requisite corporate power, right and authority under the<br \/>\n     Company Stock Plans, and all grants and awards thereunder, to take all<br \/>\n     actions contemplated by Section 6.11(f) of this Agreement, without<br \/>\n     violating any of the terms of the Company Stock Plans or any grants or<br \/>\n     awards outstanding thereunder. Except for the elections of optionees<br \/>\n     contemplated by Schedule 6.11, no consent of any holder of a Company Stock<br \/>\n     Option is required in connection with the treatment of options provided for<br \/>\n     in Schedule 6.11 of this Agreement.<\/p>\n<p>3.14  Compliance With Laws.  The Company and each of its Subsidiaries has<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\ncomplied with, is not in violation of, and has not received any notice alleging<br \/>\nany violation with respect to, any applicable provisions of any federal or state<br \/>\nstatute, law or regulation with respect to the conduct of its business, or the<br \/>\nownership or operation of its properties or assets, except for failures to<br \/>\ncomply or violations which, individually or in the aggregate, have not had, and<br \/>\nare not reasonably likely to have, a Company Material Adverse Effect.<\/p>\n<p>3.15  Permits.  The Company and each of its Subsidiaries have all permits,<br \/>\n      &#8212;&#8212;-<br \/>\nlicenses and franchises from Governmental Entities required to conduct their<br \/>\nbusinesses as now being conducted or as presently contemplated to be conducted<br \/>\n(the &#8220;Company Permits&#8221;), except for such permits, licenses and franchises the<br \/>\nabsence of which, individually or in the aggregate, have not resulted in, and<br \/>\nare not reasonably likely to result in, a Company Material Adverse Effect.  The<br \/>\nCompany and its Subsidiaries are in compliance, in all material respects, with<br \/>\nthe terms of the Company Permits.<\/p>\n<p>                                       22<\/p>\n<p>3.16  Registration Statement; Proxy Statement\/Prospectus.  The information to be<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nsupplied by the Company for inclusion in the registration statement on Form S-4<br \/>\npursuant to which shares of Buyer Common Stock issued in connection with the<br \/>\nMerger will be registered under the Securities Act (the &#8220;Registration<br \/>\nStatement&#8221;), shall not at the time the Registration Statement is declared<br \/>\neffective by the SEC contain any untrue statement of a material fact or omit to<br \/>\nstate any material fact required to be stated in the Registration Statement or<br \/>\nnecessary in order to make the statements in the Registration Statement, in<br \/>\nlight of the circumstances under which they were made, not misleading.  The<br \/>\ninformation to be supplied by the Company for inclusion in the proxy<br \/>\nstatement\/prospectus (the &#8220;Proxy Statement&#8221;) to be sent to the stockholders of<br \/>\nthe Company in connection with the meeting of the Company&#8217;s stockholders to<br \/>\nconsider this Agreement and the Merger (the &#8220;Company Meeting&#8221;) shall not, on the<br \/>\ndate the Proxy Statement is first mailed to stockholders of the Company, at the<br \/>\ntime of the Company Meeting and at the Effective Time, contain any statement<br \/>\nwhich, at such time and in light of the circumstances under which it shall be<br \/>\nmade, is false or misleading with respect to any material fact, or omit to state<br \/>\nany material fact necessary in order to make the statements made in the Proxy<br \/>\nStatement not false or misleading; or omit to state any material fact necessary<br \/>\nto correct any statement in any earlier communication with respect to the<br \/>\nsolicitation of proxies for the Company Meeting which has become false or<br \/>\nmisleading.  If at any time prior to the Effective Time any event relating to<br \/>\nthe Company or any of its Affiliates, officers or directors should be discovered<br \/>\nby the Company which should be set forth in an amendment to the Registration<br \/>\nStatement or a supplement to the Proxy Statement, the Company shall promptly<br \/>\ninform the Buyer.<\/p>\n<p>3.17  Labor Matters.  Neither the Company nor any of its Subsidiaries is a party<br \/>\n      &#8212;&#8212;&#8212;&#8212;-<br \/>\nto or otherwise bound by any collective bargaining agreement, contract or other<br \/>\nagreement or understanding with a labor union or labor organization.  Neither<br \/>\nthe Company nor any of its Subsidiaries is the subject of any proceeding<br \/>\nasserting that the Company or any of its Subsidiaries has committed an unfair<br \/>\nlabor practice or is seeking to compel it to bargain with any labor union or<br \/>\nlabor organization, nor is there pending or, to the knowledge of the Company,<br \/>\nthreatened, any labor strike, dispute, walkout, work stoppage, slow-down or<br \/>\nlockout involving the Company or any of its Subsidiaries.<\/p>\n<p>3.18  Insurance.  Each of the Company and its Subsidiaries maintains insurance<br \/>\n      &#8212;&#8212;&#8212;<br \/>\npolicies with reputable insurance carriers against all risks of a character and<br \/>\nin such amounts as are usually insured against by similarly situated companies<br \/>\nin the same or similar businesses.  Each  insurance policy is in full force and<br \/>\neffect and is valid, outstanding and enforceable, and all premiums due thereon<br \/>\nhave been paid in full.  None of the insurance policies will terminate or lapse<br \/>\n(or be affected in any other materially adverse manner) by reason of the<br \/>\ntransactions contemplated by this Agreement.  The Company and its Subsidiaries<br \/>\nhave complied in all material respects with the provisions of each insurance<br \/>\npolicy under which it is the insured party.  No <\/p>\n<p>                                       23<\/p>\n<p>insurer under any insurance policy has canceled or generally disclaimed<br \/>\nliability under any such policy or indicated any intent to do so or not to renew<br \/>\nany such policy. All material claims under the insurance policies have been<br \/>\nfiled in a timely fashion.<\/p>\n<p>3.19  Business Activity Restrictions.  There is no non-competition or other<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nsimilar agreement, commitment, judgment, injunction or order to which the<br \/>\nCompany or any Subsidiary of the Company is a party or subject to that has or<br \/>\ncould reasonably be expected to have the effect of prohibiting or impairing the<br \/>\nconduct of the business by the Company in any material respect.  Except as set<br \/>\nforth in Section 3.19 of the Company Disclosure Schedule, the Company has not<br \/>\nentered into any agreement under which it is restricted in any material respect<br \/>\nfrom selling, licensing or otherwise distributing any of its technology or<br \/>\nproducts, or providing services to, customers or potential customers or any<br \/>\nclass of customers, in any geographic area, during any period of time or any<br \/>\nsegment of the market or line of business.<\/p>\n<p>3.20  Year 2000 Compliance.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  Except as disclosed in Section 3.20(a) in the Company Disclosure Schedule,<br \/>\n     the Company has conducted &#8220;year 2000&#8221; audits with respect to (i) all of the<br \/>\n     Company&#8217;s internal systems used in the business or operations of the<br \/>\n     Company, including, without limitation, computer hardware systems, software<br \/>\n     applications, firmware, equipment firmware and other embedded systems, and<br \/>\n     (ii) the software, hardware, firmware and other technology which constitute<br \/>\n     part of the products and services marketed or sold by the Company or<br \/>\n     licensed by the Company to third parties.  The Company has obtained &#8220;year<br \/>\n     2000&#8221; certificates with respect to all material third-party systems used in<br \/>\n     connection with the business or operations of the Company.<\/p>\n<p>(b)  All of (i) the Company&#8217;s material internal systems used in the business or<br \/>\n     operations of the Company, including, without limitation, computer hardware<br \/>\n     systems, software applications, firmware, equipment containing embedded<br \/>\n     microchips and other embedded systems (the &#8220;Company Systems&#8221;), and (ii) the<br \/>\n     software, hardware, firmware and other technology which constitute part of<br \/>\n     the products and services marketed or sold by the Company or licensed by<br \/>\n     the Company to third parties (the &#8220;Company Products&#8221;) are Year 2000<br \/>\n     Compliant.<\/p>\n<p>(c)  The Company has no knowledge of any failure to be Year 2000 Compliant of<br \/>\n     any material third-party system used in connection with the business or<br \/>\n     operations of the Company.<\/p>\n<p>(d)  For purposes of this Agreement, &#8220;Year 2000 Compliant&#8221; means that the<br \/>\n     applicable system or item:<\/p>\n<p>                                       24<\/p>\n<p>(i)    accurately receives, records, stores, provides, recognizes and processes<br \/>\n       all date and time data from, during, into and between the twentieth and<br \/>\n       twenty-first centuries, the years 1999 and 2000 and all leap years;<\/p>\n<p>(ii)   accurately performs all date-dependent calculations and operations<br \/>\n       (including, without limitation, mathematical operations, sorting,<br \/>\n       comparing and reporting) from, during, into and between the twentieth and<br \/>\n       twenty-first centuries, the years 1999 and 2000 and all leap years; and<\/p>\n<p>(iii)  does not malfunction, cease to function or provide invalid or incorrect<br \/>\n       results as a result of (x) the change of years from 1999 to 2000 or from<br \/>\n       2000 to 2001, (y) date data, including date data which represents or<br \/>\n       references different centuries, different dates during 1999 and 2000, or<br \/>\n       more than one century or (z) the occurrence of any particular date;<\/p>\n<p>in each case without human intervention, other than original data entry;<br \/>\nprovided, in each case, that all applications, hardware and other systems used<br \/>\nin conjunction with such system or item which are not owned or licensed by the<br \/>\nCompany correctly exchange date data with or provide data to such system or<br \/>\nitem.<\/p>\n<p>(e)  The Company has not provided any guarantee or warranty for any Company<br \/>\n     Product to the effect that such product or service (i) complies with or<br \/>\n     accounts for the fact of the arrival of the year 2000, (ii) will not be<br \/>\n     adversely affected with respect to functionality, interoperability,<br \/>\n     performance or volume capacity (including, without limitation, the<br \/>\n     processing and reporting of data) by virtue of the arrival of the year 2000<br \/>\n     or (iii) is otherwise Year 2000 Compliant.<\/p>\n<p>3.21  Assets.  Each of the Company and its Subsidiaries owns or leases all<br \/>\n      &#8212;&#8212;<br \/>\ntangible assets necessary for the conduct of its businesses as presently<br \/>\nconducted and as presently proposed to be conducted.  Except as disclosed in<br \/>\nSection 3.21 in the Company Disclosure Schedule, all of such tangible assets<br \/>\nwhich are owned, are owned free and clear of all mortgages, security interest,<br \/>\npledges, liens and encumbrances (&#8220;Liens&#8221;) except for (i) Liens which are<br \/>\ndisclosed in the Company SEC Reports filed prior to the date of this Agreement<br \/>\nand (ii) other Liens which, individually and in the aggregate, do not materially<br \/>\ninterfere with the ability of the Company or its Subsidiaries to conduct their<br \/>\nbusiness as currently conducted and as presently proposed to be conducted and<br \/>\nhave not resulted in, and are not reasonably likely to result in, a Company<br \/>\nMaterial Adverse Effect.  The tangible assets of the Company and its<br \/>\nSubsidiaries, taken as a whole, are free from material defects, have been<br \/>\nmaintained in accordance with normal industry practice, are in good operating<br \/>\ncondition and repair (subject to normal wear and tear) and are suitable for the<br \/>\npurpose for which they are presently used.<\/p>\n<p>                                       25<\/p>\n<p>3.22  No Existing Discussions.  As of the date of this Agreement, neither the<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nCompany nor any of its Subsidiaries is engaged, directly or indirectly, in any<br \/>\ndiscussions or negotiations with any other party with respect to an Acquisition<br \/>\nProposal (as defined in Section 6.1).<\/p>\n<p>3.23  Opinion of Financial Advisor.  The financial advisor of the Company,<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nMerrill Lynch &amp; Co., Inc., has delivered to the Company an opinion, dated the<br \/>\ndate of this Agreement, to the effect that, as of such date and based upon and<br \/>\nsubject to the matters stated in the opinion, that the Exchange Ratio is fair to<br \/>\nthe holders of the Company Common Stock from a financial point of view.<\/p>\n<p>3.24  Section 203 of the DGCL Not Applicable.  The Board of Directors of the<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nCompany has taken all actions necessary so that the restrictions contained in<br \/>\nSection 203 of the DGCL applicable to a &#8220;business combination&#8221; (as defined in<br \/>\nSection 203) will not apply to the execution, delivery or performance of this<br \/>\nAgreement,  the Stockholder Agreement or the consummation of the Merger or the<br \/>\nother transactions contemplated by this Agreement, or the Stockholder Agreement.<\/p>\n<p>3.25  Tax Matters<br \/>\n      &#8212;&#8212;&#8212;&#8211;<\/p>\n<p>(a)  To the Company&#8217;s knowledge, after consulting with its independent auditors,<br \/>\n     neither the Company nor any of its Affiliates has taken or agreed to take<br \/>\n     any action which would prevent the Merger from constituting a transaction<br \/>\n     qualifying as a reorganization under Section 368(a) of the Code.<\/p>\n<p>(b)  The representations made by the Company and its Subsidiaries and, to the<br \/>\n     knowledge of the Company, the representations made by Creative Computer,<br \/>\n     Inc. (&#8220;CCI&#8221;) and the 5% shareholders of the Company and CCI in the<br \/>\n     certificates and\/or letters provided to PricewaterhouseCoopers LLP and KPMG<br \/>\n     LLP (the &#8220;Accounting Firms&#8221;) for the purpose of the Accounting Firms<br \/>\n     issuing opinions to CCI, Buyer and\/or the Company with respect to the<br \/>\n     applicability of Section 355(e)(1) of the Code to the Merger are true,<br \/>\n     correct and complete in all respects.<\/p>\n<p>3.26  Transactions with Affiliates.  Except as disclosed in the Company SEC<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nReports filed prior to the date of this Agreement, neither the Company nor any<br \/>\nof its Subsidiaries has entered into any transaction with any director, officer<br \/>\nor other affiliate of the Company or any of its Subsidiaries or any transaction<br \/>\nthat would be subject to proxy statement disclosure pursuant to Item 404 of<br \/>\nRegulation S-K.<\/p>\n<p>3.27  Brokers; Schedule of Fees and Expenses.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  No agent, broker, investment banker, financial advisor or other firm or<br \/>\n     person acting on behalf of the Company is or will be entitled to any<br \/>\n     broker&#8217;s, finder&#8217;s, financial advisor&#8217;s or other similar fee or commission<br \/>\n     in connection with any of <\/p>\n<p>                                       26<\/p>\n<p>     the transactions contemplated by this Agreement, except Merrill Lynch &amp; Co., Inc., whose fees and expense will be paid by the Company. The Company<br \/>\n     has delivered to the Buyer a complete and accurate copy of all agreements<br \/>\n     pursuant to which Merrill Lynch &amp; Co., Inc., is entitled to any fees and<br \/>\n     expenses in connection with any of the transactions contemplated by this<br \/>\n     Agreement.<\/p>\n<p>(b)  Section 3.27(b) of the Company Disclosure Schedule sets forth a complete<br \/>\n     and accurate list of the estimated fees and expenses incurred and to be<br \/>\n     incurred by the Company and any of its Subsidiaries in connection with this<br \/>\n     Agreement and the transactions contemplated by this Agreement (including<br \/>\n     the fees and expenses of Merrill Lynch &amp; Co., Inc., and of the Company&#8217;s<br \/>\n     legal counsel and accountants) and such estimated fees and expenses shall<br \/>\n     be no more than as set forth on Section 3.27(b) of the Company Disclosure<br \/>\n     Schedule.<\/p>\n<p>3.28  Privacy Issues.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  The Company&#8217;s (including any Subsidiaries) statistical models used to<br \/>\n     determine whether to post products for auction on the Company&#8217;s website<br \/>\n     have not been disclosed to any third party at any time other than to third<br \/>\n     parties who have executed nondisclosure agreements with the Company.<\/p>\n<p>(b)  The Company has implemented all reasonable steps which are known in the<br \/>\n     information systems industry and which are generally known as best<br \/>\n     practices in the physical and electronic protection of its information<br \/>\n     assets from unauthorized disclosure, use or modification.  The Company has<br \/>\n     previously disclosed to the Buyer whether, to its knowledge, there have<br \/>\n     been breaches of security, known consequences, and the steps the Company<br \/>\n     has taken to remedy any such breaches.<\/p>\n<p>(c)  The Company has conducted its business and has collected, maintained and<br \/>\n     used its data at all times materially in accordance with (i) accepted<br \/>\n     industry practice and the privacy policy of the Company as currently set<br \/>\n     forth on the company&#8217;s website; and (ii) all applicable United States<br \/>\n     federal and state laws, including but not limited to those relating to<br \/>\n     privacy.<\/p>\n<p>(d)  The electronic data processing, information, record keeping,<br \/>\n     communications, telecommunications, auction trading and computer systems<br \/>\n     and intellectual property (including software) that are used by the Company<br \/>\n     in its business (collectively, the &#8220;Technology Systems&#8221;) operate in<br \/>\n     accordance with their technical specifications and are adequate for the<br \/>\n     operation of the business of the Company as currently operated and proposed<br \/>\n     to be operated.  The Company owns or has the right to use all components of<br \/>\n     the Technology Systems, free of any rights of Creative Computers, Inc. or<br \/>\n     any other third party.  There has not been any material malfunction with<br \/>\n     respect to any of the Technology Systems since December 31, 1996 that has<br \/>\n     not been remedied or replaced without disruption to the business of the<br \/>\n     Company.<\/p>\n<p>                                       27<\/p>\n<p>                                  ARTICLE IV<br \/>\n   REPRESENTATIONS AND WARRANTIES OF THE BUYER AND THE TRANSITORY SUBSIDIARY<\/p>\n<p>     The Buyer and the Transitory Subsidiary represent and warrant to the<br \/>\nCompany that the statements contained in this Article IV are true and correct,<br \/>\nexcept as set forth herein or in the Buyer disclosure schedule delivered by the<br \/>\nBuyer to the Company on or before the date of this Agreement (the &#8220;Buyer<br \/>\nDisclosure Schedule&#8221;).  The Buyer Disclosure Schedule shall be arranged in<br \/>\nparagraphs corresponding to the numbered and lettered paragraphs contained in<br \/>\nthis Article IV and the disclosure in any paragraph shall qualify other<br \/>\nparagraphs in this Article IV only to the extent that it is reasonably apparent<br \/>\nfrom a reading of such document that it also qualifies or applies to such other<br \/>\nparagraphs.<\/p>\n<p>4.1  Organization, Standing and Power.  Each of the Buyer and the Transitory<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSubsidiary and the Buyer&#8217;s other Subsidiaries is a corporation duly organized,<br \/>\nvalidly existing and in good standing under the laws of the jurisdiction of its<br \/>\nincorporation, has all requisite corporate power and authority to own, lease and<br \/>\noperate its properties and assets and to carry on its business as now being<br \/>\nconducted and as proposed to be conducted, and is duly qualified to do business<br \/>\nand is in good standing as a foreign corporation in each jurisdiction in which<br \/>\nthe failure to be so qualified, individually or in the aggregate, would be<br \/>\nreasonably likely to have a material adverse effect on the business, properties,<br \/>\nfinancial condition, results of operations or prospects of the Buyer and its<br \/>\nSubsidiaries, taken as a whole, or to have a material adverse effect on the<br \/>\nability of the Buyer to consummate the transactions contemplated by this<br \/>\nAgreement (a &#8220;Buyer Material Adverse Effect&#8221;).<\/p>\n<p>4.2  Capitalization.  The authorized capital stock of the Buyer consists of<br \/>\n      &#8212;&#8212;&#8212;&#8212;-<br \/>\n400,000,000 shares of Buyer Common Stock and 5,000,000 shares of preferred<br \/>\nstock, $.01 par value per share (the &#8220;Buyer Preferred Stock&#8221;), of which<br \/>\n(i) 250 shares are designated Series A Preferred Stock, (ii) 50,000 shares are<br \/>\ndesignated Series B Preferred Stock, (iii) 375,000 shares are designated Series<br \/>\nC Preferred Stock and (iv) 18,090.45 shares are designated Series D Preferred<br \/>\nStock. As of the close of business on January 26, 2000, 265,342,554 shares of<br \/>\nBuyer Common Stock were issued and outstanding, and (i) no shares of Series A<br \/>\nPreferred Stock, (ii) 35,000 shares of Series B Preferred Stock (convertible<br \/>\ninto an aggregate of 2,808,556 shares of Buyer Common Stock), (iii) 375,000<br \/>\nshares of Series C Preferred Stock (convertible into an aggregate of 9,488,056<br \/>\nshares of Buyer Common Stock), and (iv) no shares of Series D Preferred Stock<br \/>\nwere issued and outstanding. All outstanding shares of Buyer Common Stock are,<br \/>\nand all shares of Buyer Common Stock subject to issuance as specified above,<br \/>\nupon issuance on the terms and conditions specified in the instruments pursuant<br \/>\nto which they are issuable, will be, duly authorized, validly issued, fully paid<br \/>\nand nonassessable. All of the shares of Buyer Common Stock issuable pursuant to<br \/>\nSection 2.1(c) in connection with the<\/p>\n<p>                                       28<\/p>\n<p>Merger, when issued in accordance with this Agreement, will be duly authorized,<br \/>\nvalidly issued, fully paid and nonassessable.<\/p>\n<p>4.3  Authority; No Conflict; Required Filings and Consents.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  Each of the Buyer and the Transitory Subsidiary has all requisite corporate<br \/>\n     power and authority to enter into this Agreement and to consummate the<br \/>\n     transactions contemplated by this Agreement.  The execution and delivery of<br \/>\n     this Agreement and the consummation of the transactions contemplated by<br \/>\n     this Agreement by the Buyer and the Transitory Subsidiary have been duly<br \/>\n     authorized by all necessary corporate action on the part of each of the<br \/>\n     Buyer and the Transitory Subsidiary, including the approval of the Merger<br \/>\n     by the Buyer in its capacity as sole stockholder of the Transitory<br \/>\n     Subsidiary.  This Agreement has been duly executed and delivered by each of<br \/>\n     the Buyer and the Transitory Subsidiary and constitutes the valid and<br \/>\n     binding obligation of each of the Buyer and the Transitory Subsidiary,<br \/>\n     enforceable in accordance with its terms.<\/p>\n<p>(b)  The execution and delivery of this Agreement by each of the Buyer and the<br \/>\n     Transitory Subsidiary does not, and the consummation of the transactions<br \/>\n     contemplated by this Agreement will not, (i) conflict with, or result in<br \/>\n     any violation or breach of, any provision of the Certificate of<br \/>\n     Incorporation or By-laws of the Buyer or the Transitory Subsidiary,<br \/>\n     (ii) conflict with, or result in any violation or breach of, or constitute<br \/>\n     (with or without notice or lapse of time, or both) a default (or give rise<br \/>\n     to a right of termination, cancellation or acceleration of any obligation<br \/>\n     or loss of any material benefit) under, or require a consent or waiver<br \/>\n     under, any of the terms, conditions or provisions of any note, bond,<br \/>\n     mortgage, indenture, lease, license, contract or other agreement,<br \/>\n     instrument or obligation to which the Buyer or any of its Subsidiaries is a<br \/>\n     party or by which any of them or any of their properties or assets may be<br \/>\n     bound, or (iii) subject to compliance with the requirements specified in<br \/>\n     clause (i), (ii), (iii), (iv), (v) and (vi) of Section 4.3(c), conflict<br \/>\n     with or violate any permit, concession, franchise, license, judgment,<br \/>\n     injunction, order, decree, statute, law, ordinance, rule or regulation<br \/>\n     applicable to the Buyer or any of its Subsidiaries or any of its or their<br \/>\n     properties or assets, except in the case of (ii) and (iii) for any such<br \/>\n     conflicts, violations, breaches, defaults, terminations, cancellations or<br \/>\n     accelerations which, individually or in the aggregate, are not reasonably<br \/>\n     likely to have a Buyer Material Adverse Effect.<\/p>\n<p>(c)  No consent, approval, license, permit, order or authorization of, or<br \/>\n     registration, declaration, notice or filing with, any Governmental Entity<br \/>\n     is required by or with respect to the Buyer or any of its Subsidiaries in<br \/>\n     connection with the execution and delivery of this Agreement by the Buyer<br \/>\n     or the Transitory Subsidiary or the consummation of the transactions<br \/>\n     contemplated by this Agreement, except for (i) the filing of a pre-merger<br \/>\n     notification report under the HSR Act, (ii) the filing of the Certificate<br \/>\n     of Merger with the Delaware Secretary of State, (iii) the filing of the<br \/>\n     Registration Statement with the SEC in accordance with the Securities Act,<br \/>\n     (iv) the <\/p>\n<p>                                       29<\/p>\n<p>     filings of such reports or schedules under Section 13 of the Exchange Act<br \/>\n     as may be required in connection with this Agreement and the transactions<br \/>\n     contemplated hereby, (v) such consents, approvals, orders, authorizations,<br \/>\n     registrations, declarations and filings as may be required under applicable<br \/>\n     state securities laws and (vi) the filing with the Nasdaq National Market<br \/>\n     of a Notification Form for Listing of Additional Shares with respect to the<br \/>\n     Buyer Common Stock issuable in connection with the Merger.<\/p>\n<p>4.4  SEC Filings; Financial Statements.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  The Buyer has filed and made available to the Company all forms, reports<br \/>\n     and other documents required to be filed by the Buyer with the SEC since<br \/>\n     June 1, 1998.  All such required forms, reports and other documents<br \/>\n     (including those that the Buyer may file after the date hereof until the<br \/>\n     Closing) are referred to herein as the &#8220;Buyer SEC Reports.&#8221;  The Buyer SEC<br \/>\n     Reports (i) were or will be filed on a timely basis, (ii) were or will be<br \/>\n     prepared in compliance in all material respects with the applicable<br \/>\n     requirements of the Securities Act and the Exchange Act, as the case may<br \/>\n     be, and the rules and regulations of the SEC thereunder applicable to such<br \/>\n     Buyer SEC Reports, and (iii) did not or will not at the time they were or<br \/>\n     are filed contain any untrue statement of a material fact or omit to state<br \/>\n     a material fact required to be stated in such Buyer SEC Reports or<br \/>\n     necessary in order to make the statements in such Buyer SEC Reports, in the<br \/>\n     light of the circumstances under which they were made, not misleading.<\/p>\n<p>(b)  Each of the consolidated financial statements (including, in each case, any<br \/>\n     related notes and schedules) contained or to be contained in the Buyer SEC<br \/>\n     Reports (i) complied or will comply as to form in all material respects<br \/>\n     with applicable  accounting requirements and the published rules and<br \/>\n     regulations of the SEC with respect thereto, (ii) were or will be prepared<br \/>\n     in accordance with United States generally accepted accounting principles<br \/>\n     applied on a consistent basis throughout the periods involved (except as<br \/>\n     may be indicated in the notes to such financial statements or, in the case<br \/>\n     of unaudited statements, as permitted by the SEC on Form 10-Q under the<br \/>\n     Exchange Act) and (iii) fairly presented or will fairly present the<br \/>\n     consolidated financial position of the Buyer and its Subsidiaries as of the<br \/>\n     dates and the consolidated results of its operations and cash flows for the<br \/>\n     periods indicated, consistent with the books and records of the Buyer and<br \/>\n     its Subsidiaries, except that the unaudited interim financial statements<br \/>\n     were or are subject to normal and recurring year-end adjustments which were<br \/>\n     not or are not expected to be material in amount. The audited balance sheet<br \/>\n     of the Buyer as of July 31, 1999 is referred to herein as the &#8220;Buyer<br \/>\n     Balance Sheet.&#8221;<\/p>\n<p>4.5  Absence of Certain Changes or Events.  Except as disclosed in the Buyer SEC<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nReports filed prior to the date of this Agreement, since the date of the Buyer<br \/>\nBalance Sheet, there has not been any event, change or development in the<br \/>\nbusiness, properties, financial condition, results of operations or prospects of<br \/>\nthe Buyer and its <\/p>\n<p>                                       30<\/p>\n<p>Subsidiaries, taken as a whole, which has had, or is reasonably likely to have,<br \/>\na Buyer Material Adverse Effect.<\/p>\n<p>4.6  Tax Matters.  To the Buyer&#8217;s knowledge, after consulting with its<br \/>\n     &#8212;&#8212;&#8212;&#8211;<br \/>\nindependent auditors, neither the Buyer nor any of its Affiliates has taken or<br \/>\nagreed to take any action which would prevent the Merger from constituting a<br \/>\ntransaction qualifying as a reorganization under Section 368(a) of the Code.<\/p>\n<p>4.7  Registration Statement; Proxy Statement\/Prospectus.  The information in the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nRegistration Statement (except for information supplied by the Company for<br \/>\ninclusion in the Registration Statement, as to which the Buyer makes no<br \/>\nrepresentation and which shall not constitute part of the Buyer SEC Reports for<br \/>\npurposes of this Agreement) shall not at the time the Registration Statement is<br \/>\ndeclared effective by the SEC contain any untrue statement of a material fact or<br \/>\nomit to state any material fact required to be stated in the Registration<br \/>\nStatement or necessary in order to make the statements in the Registration<br \/>\nStatement, in light of the circumstances under which they were made, not<br \/>\nmisleading.  If at any time prior to the Effective Time any event relating to<br \/>\nthe Buyer or any of its Affiliates, officers or directors should be discovered<br \/>\nby the Buyer which should be set forth in an amendment to the Registration<br \/>\nStatement, the Buyer shall promptly inform the Company.<\/p>\n<p>4.8  Litigation.  Except as disclosed in the Buyer SEC Reports filed prior to<br \/>\n     &#8212;&#8212;&#8212;-<br \/>\nthe date of this Agreement, there is no action, suit, proceeding, claim,<br \/>\narbitration or investigation pending or, to the knowledge of the Buyer,<br \/>\nthreatened against or affecting the Buyer or any of its Subsidiaries which,<br \/>\nindividually or in the aggregate, has had, or is reasonably likely to have, a<br \/>\nBuyer Material Adverse Effect.  There are no material judgments, orders or<br \/>\ndecrees outstanding against the Buyer.<\/p>\n<p>4.9  Operations of the Transitory Subsidiary.  The Transitory Subsidiary has<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nengaged in no business activities other than as contemplated by this Agreement<br \/>\nand has conducted its operations only as contemplated by this Agreement.<\/p>\n<p>4.10  Brokers. No agent, broker, investment banker, financial advisor or other<br \/>\n      &#8212;&#8212;-<br \/>\nfirm or person acting on Buyer&#8217;s behalf is or will be entitled to any broker&#8217;s,<br \/>\nfinder&#8217;s, financial advisor&#8217;s or other similar fee or commission in connection<br \/>\nwith any of the transactions contemplated by this Agreement, except for<br \/>\nGreenhill &amp; Co., whose fees and expense will be paid by the Buyer.<\/p>\n<p>                                   ARTICLE V<br \/>\n                              CONDUCT OF BUSINESS<\/p>\n<p>5.1  Covenants of the Company.  Except as expressly provided herein or as<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nconsented to in writing by the Buyer, from and after the date of this Agreement<br \/>\nuntil the earlier of the termination of this Agreement in accordance with its<br \/>\nterms or the Effective <\/p>\n<p>                                       31<\/p>\n<p>Time, the Company shall, and shall cause each of its Subsidiaries to, act and<br \/>\ncarry on its business in the usual, regular and ordinary course in substantially<br \/>\nthe same manner as previously conducted, and use all reasonable efforts,<br \/>\nconsistent with past practices, to maintain and preserve its and each<br \/>\nSubsidiary&#8217;s business organization, assets and properties, keep available the<br \/>\nservices of its present officers and employees and preserve its advantageous<br \/>\nbusiness relationships with customers, suppliers, distributors and others having<br \/>\nbusiness dealings with it to the end that its goodwill and ongoing business<br \/>\nshall be unimpaired at the Effective Time. Without limiting the generality of<br \/>\nthe foregoing, from and after the date of this Agreement until the earlier of<br \/>\nthe termination of this Agreement in accordance with its terms or the Effective<br \/>\nTime, the Company shall not, and shall not permit any of its Subsidiaries to,<br \/>\ndirectly or indirectly, do any of the following without the prior written<br \/>\nconsent of the Buyer:<\/p>\n<p>(a)  (A)  declare, set aside or pay any dividends on, or make any other<br \/>\n     distributions (whether in cash, securities or other property) in respect<br \/>\n     of, any of its capital stock (other than dividends and distributions by a<br \/>\n     direct or indirect wholly owned subsidiary of the Company to its parent);<br \/>\n     (B) split, combine or reclassify any of its capital stock or issue or<br \/>\n     authorize the issuance of any other securities in respect of, in lieu of or<br \/>\n     in substitution of shares of its capital stock; or (C) purchase, redeem or<br \/>\n     otherwise acquire any shares of its capital stock or any other securities<br \/>\n     thereof or any rights, warrants or options to acquire any such shares or<br \/>\n     other securities (other than repurchases at cost from employees upon<br \/>\n     termination of their employment);<\/p>\n<p>(b)  issue, deliver, sell, grant, pledge or otherwise dispose of or encumber any<br \/>\n     shares of its capital stock, any other voting securities or any securities<br \/>\n     convertible into or exchangeable for, or any rights, warrants or options to<br \/>\n     acquire, any such shares, voting securities or convertible or exchangeable<br \/>\n     securities (other than the issuance of shares of Company Common Stock upon<br \/>\n     the exercise of Company Options or Company Warrants outstanding on the date<br \/>\n     of this Agreement in accordance with their present terms);<\/p>\n<p>(c)  amend its certificate of incorporation, by-laws or other comparable charter<br \/>\n     or organizational documents, except as expressly provided by this<br \/>\n     Agreement;<\/p>\n<p>(d)  acquire (A) by merging or consolidating with, or by purchasing a<br \/>\n     substantial portion of the assets or any stock of, or by any other manner,<br \/>\n     any business or any corporation, partnership, joint venture, limited<br \/>\n     liability company, association or other business organization or division<br \/>\n     thereof or (B) any assets that are material, in the aggregate, to the<br \/>\n     Company and the Subsidiaries, taken as a whole, except purchases of<br \/>\n     inventory in the ordinary course of business consistent with past practice;<\/p>\n<p>(e)  except in the ordinary course of business consistent with past practice,<br \/>\n     sell, lease, license, pledge, or otherwise dispose of or encumber any<br \/>\n     properties or assets of the Company or of any of its Subsidiaries;<\/p>\n<p>                                       32<\/p>\n<p>(f)  whether or not in the ordinary course of business or consistent with past<br \/>\n     practice, sell or dispose of any assets material to the Company and its<br \/>\n     Subsidiaries, taken as a whole (including any accounts, leases, contracts<br \/>\n     or intellectual property or any assets or the stock of any Subsidiaries,<br \/>\n     but excluding the sale of products and services in the ordinary course of<br \/>\n     business consistent with past practice);<\/p>\n<p>(g)  adopt or implement any stockholder rights plan;<\/p>\n<p>(h)  except as permitted by Section 6.1, enter into an agreement with respect to<br \/>\n     any merger, consolidation, liquidation or business combination, or any<br \/>\n     acquisition or disposition of all or substantially all of the assets or<br \/>\n     securities of the Company or any of its Subsidiaries;<\/p>\n<p>(i)  (A) incur or suffer to exist any indebtedness for borrowed money other than<br \/>\n     such indebtedness which existed as of [November 30, 1999] as reflected on<br \/>\n     the Company Balance Sheet or guarantee any such indebtedness of another<br \/>\n     person, (B) issue or sell any debt securities or warrants or other rights<br \/>\n     to acquire any debt securities of the Company or any of its Subsidiaries,<br \/>\n     guarantee any debt securities of another person, enter into any &#8220;keep well&#8221;<br \/>\n     or other agreement to maintain any financial statement condition of another<br \/>\n     person or enter into any arrangement having the economic effect of any of<br \/>\n     the foregoing, other than the incurrence of accounts payable in the<br \/>\n     ordinary course of business, or (C) make any loans, advances (other than<br \/>\n     routine advances to employees of the company in the ordinary course of<br \/>\n     business consistent with past practice) or capital contributions to, or<br \/>\n     investment in, any other person;<\/p>\n<p>(j)  make any capital expenditures or expenditures for property, plant or<br \/>\n     equipment, except consistent with the capital budget shown on<br \/>\n     Section 5.1(j) of the Company Disclosure Schedule;<\/p>\n<p>(k)  make any changes in accounting methods, principles or practices, except<br \/>\n     insofar as may have been required by a change in United States generally<br \/>\n     accepted accounting principles or, except as so required, change any<br \/>\n     assumption underlying, or method of calculating, any bad debt, contingency<br \/>\n     or other reserve;<\/p>\n<p>(l)  (A) pay, discharge, settle or satisfy any claims, liabilities or<br \/>\n     obligations (absolute, accrued, asserted or unasserted, contingent or<br \/>\n     otherwise), other than the payment, discharge or satisfaction, in the<br \/>\n     ordinary course of business consistent with past practice or in accordance<br \/>\n     with their terms, of liabilities reflected or reserved against in, or<br \/>\n     contemplated by, the most recent consolidated financial statements (or the<br \/>\n     notes thereto) of the Company included in the Company SEC Reports filed<br \/>\n     prior to the date of this Agreement (to the extent so reflected or reserved<br \/>\n     against) or incurred thereafter in the ordinary course of business<br \/>\n     consistent with past practice, or (B) except as permitted under Section<br \/>\n     6.1, waive any material benefits of any <\/p>\n<p>                                       33<\/p>\n<p>     confidentiality, standstill or similar agreements to which the Company or<br \/>\n     any of its Subsidiaries is a party;<\/p>\n<p>(m)  except in the ordinary course of business, modify, amend or terminate any<br \/>\n     material contract or agreement to which the Company or any of its<br \/>\n     Subsidiaries is party, or knowingly waive, release or assign any material<br \/>\n     rights or claims (including any write-off or other compromise of any<br \/>\n     accounts receivable of the Company or any of its Subsidiaries);<\/p>\n<p>(n)  (A) except in the ordinary course of business consistent with past<br \/>\n     practice, enter into any material contract or agreement or (B) license any<br \/>\n     material intellectual property rights to or from any third party;<\/p>\n<p>(o)  except as required to comply with applicable law or agreements, plans or<br \/>\n     arrangements existing on the date hereof or as contemplated by this<br \/>\n     Agreement or disclosed on Section 5.1(o) of the Company Disclosure<br \/>\n     Schedule, (A) adopt, enter into, terminate or amend any employment,<br \/>\n     severance or similar agreement or benefit plan for the benefit or welfare<br \/>\n     of any current or former director, officer or employee or any collective<br \/>\n     bargaining agreement, (B) increase in any material respect the compensation<br \/>\n     or fringe benefits of, or pay any bonus to, any director, officer or key<br \/>\n     employee, (C) accelerate the payment, right to payment or vesting of any<br \/>\n     compensation or benefits, including any outstanding options or restricted<br \/>\n     stock awards, (D) pay any material benefit not provided for as of the date<br \/>\n     of this Agreement under any benefit plan, (E) grant any awards under any<br \/>\n     bonus, incentive, performance or other compensation plan or arrangement or<br \/>\n     benefit plan (including the grant of stock options, stock appreciation<br \/>\n     rights, stock based or stock related awards, performance units or<br \/>\n     restricted stock, or the removal of existing restrictions in any benefit<br \/>\n     plans or agreements or awards made thereunder) except for the grant of<br \/>\n     Permitted Options, or (F) take any action other than in the ordinary course<br \/>\n     of business consistent with past practice to fund or in any other way<br \/>\n     secure the payment of compensation or benefits under any employee plan,<br \/>\n     agreement, contract or arrangement or benefit plan;<\/p>\n<p>(p)  make or rescind any Tax election, settle or compromise any Tax liability or<br \/>\n     amend any Tax return;<\/p>\n<p>(q)  initiate, compromise or settle any material litigation or arbitration<br \/>\n     proceeding;<\/p>\n<p>(r)  close any facility or office;<\/p>\n<p>(s)  invest funds in debt securities or other instruments maturing more than 90<br \/>\n     days after the date of investment; or<\/p>\n<p>                                       34<\/p>\n<p>(t)  authorize any of, or commit or agree, in writing or otherwise, to take any<br \/>\n     of, the foregoing actions or any action which would materially impair or<br \/>\n     prevent the occurrence of any conditions of Article VII hereof.<\/p>\n<p>5.2  Cooperation.  Subject to compliance with applicable law, from and after the<br \/>\n     &#8212;&#8212;&#8212;&#8211;<br \/>\ndate of this Agreement and continuing until the earlier of the termination of<br \/>\nthis Agreement in accordance with its terms or the Effective Time, the Company<br \/>\nand each of its Subsidiaries shall make its officers available to confer on a<br \/>\nregular and frequent basis with one or more representatives of the Buyer to<br \/>\nreport on the general status of ongoing operations and shall promptly provide<br \/>\nthe Buyer or its counsel with copies of all filings made by such party with any<br \/>\nGovernmental Entity in connection with this Agreement, the Merger and the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>5.3  Confidentiality.  The parties acknowledge that the Buyer and the Company<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nhave previously executed a Mutual Confidentiality Agreement, dated as of January<br \/>\n14, 2000 (the &#8220;Confidentiality Agreement&#8221;), which Confidentiality Agreement will<br \/>\ncontinue in full force and effect in accordance with its terms, except as<br \/>\nexpressly modified herein.<\/p>\n<p>                                  ARTICLE VI<br \/>\n                             ADDITIONAL AGREEMENTS<\/p>\n<p>6.1  No Solicitation.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  From and after the date of this Agreement until the earlier of the<br \/>\n     termination of this Agreement in accordance with its terms or the Effective<br \/>\n     Time, the Company and its Subsidiaries shall not, directly or indirectly,<br \/>\n     through any officer, director, employee, financial advisor, representative<br \/>\n     or agent (i) solicit, initiate, or encourage any inquiries or proposals<br \/>\n     that constitute, or could reasonably be expected to lead to, a proposal or<br \/>\n     offer for a merger, consolidation, business combination, sale of<br \/>\n     substantial assets, tender offer, sale of shares of capital stock<br \/>\n     (excluding sales pursuant to existing Company Stock Plans or pursuant to<br \/>\n     the Company Warrants) or similar transaction involving the Company or any<br \/>\n     of its Subsidiaries, other than the transactions contemplated by this<br \/>\n     Agreement (any of the foregoing inquiries or proposals being referred to in<br \/>\n     this Agreement as an &#8220;Acquisition Proposal&#8221;), (ii) engage in negotiations<br \/>\n     or discussions concerning, or provide any information to any person or<br \/>\n     entity relating to, any Acquisition Proposal, or (iii) agree to or<br \/>\n     recommend any Acquisition Proposal; provided, however, that, if the Company<br \/>\n                                         &#8212;&#8212;&#8211;  &#8212;&#8212;-<br \/>\n     has not breached this Section 6.1, nothing contained in this Agreement<br \/>\n     shall prevent the Company or its Board of Directors, prior to the adoption<br \/>\n     of this Agreement by the stockholders of the Company, from:<\/p>\n<p>(A)  furnishing information to, or entering into discussions or negotiations<br \/>\n     with, any person or entity in connection with an unsolicited bona fide<\/p>\n<p>                                       35<\/p>\n<p>     written Acquisition Proposal by such person or entity or recommending an<br \/>\n     unsolicited bona fide written Acquisition Proposal to the stockholders of<br \/>\n     the Company, if and only to the extent that<\/p>\n<p>(1)  the Board of Directors of the Company believes in good faith (after<br \/>\n     consultation with its financial advisor) that such Acquisition Proposal is<br \/>\n     reasonably capable of being completed on the terms proposed and would, if<br \/>\n     consummated, result in a transaction more favorable than the transaction<br \/>\n     contemplated by this Agreement (any such more favorable Acquisition<br \/>\n     Proposal being referred to in this Agreement as a &#8220;Superior Proposal&#8221;) and<br \/>\n     the Company&#8217;s Board of Directors determines in good faith after<br \/>\n     consultation with outside legal counsel that such action is necessary for<br \/>\n     such Board of Directors to fulfill its fiduciary duties,<\/p>\n<p>(2)  prior to furnishing such non-public information to, or entering into<br \/>\n     discussions or negotiations with, such person or entity, such Board of<br \/>\n     Directors receives from such person or entity an executed confidentiality<br \/>\n     agreement with terms no less favorable to such party than those contained<br \/>\n     in the Confidentiality Agreement, and<\/p>\n<p>(3)  prior to recommending a Superior Proposal or terminating this Agreement in<br \/>\n     respect thereof, the Company shall provide the Buyer with at least five<br \/>\n     business days&#8217; prior notice of its proposal to do so, during which time the<br \/>\n     Buyer may make, and in such event the Company shall consider, a<br \/>\n     counterproposal to such Superior Proposal, and the Company shall itself and<br \/>\n     shall cause its financial and legal advisors to negotiate with the Buyer<br \/>\n     with respect to the terms and conditions of such counterproposal; or<\/p>\n<p>(B)  complying with Rule 14d-9 and 14e-2 promulgated under the Exchange Act with<br \/>\n     regard to an Acquisition Proposal; provided, however, that neither the<br \/>\n                                        &#8212;&#8212;&#8211;  &#8212;&#8212;-<br \/>\n     Company nor its Board of Directors shall, except as permitted by paragraph<br \/>\n     (A) of this section, propose to approve or recommend an Acquisition<br \/>\n     Proposal.<\/p>\n<p>(b)  The Company will immediately cease any and all existing activities,<br \/>\n     discussions or negotiations with any parties conducted heretofore of the<br \/>\n     nature described in Section 6.1(a) and will use reasonable efforts to<br \/>\n     obtain the return of any confidential information furnished to any such<br \/>\n     parties.<\/p>\n<p>(c)  The Company shall notify the Buyer immediately (but in any event, within<br \/>\n     one (1) business day) after receipt by the Company (or its advisors) of any<br \/>\n     Acquisition Proposal or any request for nonpublic information in connection<br \/>\n     with an Acquisition Proposal or for access to the properties, books or<br \/>\n     records of the Company by any person or entity that informs the Company<br \/>\n     that it is considering making, or has made, an Acquisition Proposal.  Such<br \/>\n     notice shall be made orally and in writing and shall indicate in reasonable<br \/>\n     detail the identity of the offer and the terms and conditions <\/p>\n<p>                                       36<\/p>\n<p>     of such proposal, inquiry or contact. The Company shall continue to keep<br \/>\n     the Buyer promptly informed of any change in the status of any such<br \/>\n     discussions or negotiations and the terms being discussed or negotiated.<\/p>\n<p>(d)  Nothing in this Section 6.1 shall (i) permit the Company to terminate this<br \/>\n     Agreement (except as specifically provided in Section 8.1 hereof), or<br \/>\n     (ii) permit the Company to enter into any agreement with respect to an<br \/>\n     Acquisition Proposal during the term of this Agreement (other than a<br \/>\n     confidentiality agreement of the type referred to in Section 6.1(a) above).<\/p>\n<p>(e)  Without limiting the foregoing, it is understood that any violation of the<br \/>\n     restrictions set forth in this Section 6.1 by any director or officer of<br \/>\n     the Company or any of its Subsidiaries or any investment banker, financial<br \/>\n     advisor, attorney, accountant or other representative of the Company or any<br \/>\n     of its Subsidiaries shall be deemed to be a breach of this Section 6.1 by<br \/>\n     the Company.<\/p>\n<p>6.2  Proxy Statement\/Prospectus; Registration Statement.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  As promptly as practicable after the execution of this Agreement, the Buyer<br \/>\n     and the Company shall prepare and the Company shall file with the SEC the<br \/>\n     Proxy Statement, and the Buyer shall prepare and file with the SEC the<br \/>\n     Registration Statement, in which the Proxy Statement will be included as a<br \/>\n     prospectus, provided that the Buyer may delay the filing of the<br \/>\n     Registration Statement until approval of the Proxy Statement by the SEC.<br \/>\n     The Buyer and the Company shall use reasonable efforts to cause the<br \/>\n     Registration Statement to become effective as soon after such filing as<br \/>\n     practicable.  Each of the Buyer and the Company will respond to any<br \/>\n     comments of the SEC and will use its respective reasonable efforts to have<br \/>\n     the Proxy Statement cleared by the SEC and the Registration Statement<br \/>\n     declared effective under the Securities Act as promptly as practicable<br \/>\n     after such filings and the Company will cause the Proxy Statement and the<br \/>\n     prospectus contained within the Registration Statement to be mailed to its<br \/>\n     stockholders at the earliest practicable time after both the Proxy<br \/>\n     Statement is cleared by the SEC and the Registration Statement is declared<br \/>\n     effective under the Securities Act.  Each of the Buyer and the Company will<br \/>\n     notify the other promptly upon the receipt of any comments from the SEC or<br \/>\n     its staff or any other government officials and of any request by the SEC<br \/>\n     or its staff or any other government officials for amendments or<br \/>\n     supplements to the Registration Statement, the Proxy Statement or any<br \/>\n     filing pursuant to Section 6.2(b) or for additional information and will<br \/>\n     supply the other with copies of all correspondence between such party or<br \/>\n     any of its representatives, on the one hand, and the SEC, or its staff or<br \/>\n     any other government officials, on the other hand, with respect to the<br \/>\n     Registration Statement, the Proxy Statement, the Merger or any filing<br \/>\n     pursuant to Section 6.2(b).  Each of the Buyer and the Company will cause<br \/>\n     all documents that it is responsible for filing with the SEC or other<br \/>\n     regulatory authorities under this Section 6.2 to comply in all material<br \/>\n     respects with all applicable requirements of law and the rules and<br \/>\n     regulations promulgated thereunder.  Whenever any event <\/p>\n<p>                                       37<\/p>\n<p>     occurs which is required to be set forth in an amendment or supplement to<br \/>\n     the Proxy Statement, the Registration Statement or any filing pursuant to<br \/>\n     Section 6.2(b), the Buyer or the Company, as the case may be, will promptly<br \/>\n     inform the other of such occurrence and cooperate in filing with the SEC or<br \/>\n     its staff or any other government officials, and\/or mailing to stockholders<br \/>\n     of the Company, such amendment or supplement.<\/p>\n<p>(b)  The Buyer and the Company shall make all necessary filings with respect to<br \/>\n     the Merger under the Securities Act, the Exchange Act, applicable state<br \/>\n     blue sky laws and the rules and regulations thereunder.<\/p>\n<p>6.3  Nasdaq Quotation.  The Company agrees to continue the quotation of the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nCompany Common Stock on the Nasdaq National Market during the term of this<br \/>\nAgreement.<\/p>\n<p>6.4  Access to Information.  The Company shall (and shall cause each of its<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nSubsidiaries to) afford to the Buyer&#8217;s officers, employees, accountants, counsel<br \/>\nand other representatives, reasonable access, during normal business hours<br \/>\nduring the period prior to the Effective Time, to all its properties, books,<br \/>\ncontracts, commitments, personnel and records and, during such period, the<br \/>\nCompany shall (and shall cause each of its Subsidiaries to) furnish promptly to<br \/>\nthe Buyer (a) a copy of each report, schedule, registration statement and other<br \/>\ndocument filed or received by it during such period pursuant to the requirements<br \/>\nof federal or state securities laws and (b) all other information concerning its<br \/>\nbusiness, properties, assets and personnel as the Buyer may reasonably request.<br \/>\nUnless otherwise required by law, the Buyer will hold any such information which<br \/>\nis nonpublic in confidence in accordance with the Confidentiality Agreement.  No<br \/>\ninformation or knowledge obtained in any investigation pursuant to this Section<br \/>\nor otherwise shall affect or be deemed to modify any representation or warranty<br \/>\ncontained in this Agreement or the conditions to the obligations of the parties<br \/>\nto consummate the Merger.<\/p>\n<p>6.5  Stockholders Meeting.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  The Company, acting through its Board of Directors, shall, subject to and<br \/>\n     according to applicable law and its Certificate of Incorporation and By-<br \/>\n     laws, promptly and duly call, give notice of, convene and hold as soon as<br \/>\n     practicable following the date on which the Registration Statement becomes<br \/>\n     effective the Company Meeting for the purpose of voting to approve and<br \/>\n     adopt this Agreement and the Merger (the &#8220;Company Voting Proposal&#8221;).  The<br \/>\n     Board of Directors of the Company shall (i) recommend approval and adoption<br \/>\n     of the Company Voting Proposal by the stockholders of the Company and<br \/>\n     include in the Proxy Statement such recommendation and (ii) take all<br \/>\n     reasonable and lawful action to solicit and obtain such approval; provided,<br \/>\n     however, that the Board of Directors of the Company may withdraw such<br \/>\n     recommendation if (but only if) such Board of Directors has received a<br \/>\n     Superior Proposal and after consultation with its outside legal counsel<br \/>\n     determines that it is <\/p>\n<p>                                       38<\/p>\n<p>     required, in order to fulfill its fiduciary duties under applicable law, to<br \/>\n     recommend such Superior Proposal to the stockholders of the Company and<br \/>\n     (iii) the Company has complied with the provisions of Section 6.1.<\/p>\n<p>(b)  The Company shall call and hold the Company Meeting for the purpose of<br \/>\n     voting upon the adoption of this Agreement and the Merger whether its Board<br \/>\n     of Directors at any time subsequent to the date hereof determines that this<br \/>\n     Agreement is no longer advisable and withdraws, or proposes publicly to<br \/>\n     withdraw, its approval or recommendation of this Agreement or the Merger,<br \/>\n     or approves or recommends, or proposes publicly to approve or recommend,<br \/>\n     any Superior Proposal.<\/p>\n<p>6.6  Legal Conditions to the Merger.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  Subject to the terms hereof, the Company and the Buyer shall each use its<br \/>\n     reasonable efforts to (i) take, or cause to be taken, all actions, and do,<br \/>\n     or cause to be done, and to assist and cooperate with the other parties in<br \/>\n     doing, all things necessary, proper or advisable to consummate and make<br \/>\n     effective the transactions contemplated hereby as promptly as practicable,<br \/>\n     (ii) obtain from any Governmental Entity or any other third party any<br \/>\n     consents, licenses, permits, waivers, approvals, authorizations, or orders<br \/>\n     required to be obtained or made by the Company or the Buyer or any of their<br \/>\n     Subsidiaries in connection with the authorization, execution and delivery<br \/>\n     of this Agreement and the consummation of the transactions contemplated<br \/>\n     hereby, (iii) as promptly as practicable, make all necessary filings, and<br \/>\n     thereafter make any other required submissions, with respect to this<br \/>\n     Agreement and the Merger required under (A) the Securities Act and the<br \/>\n     Exchange Act, and any other applicable federal or state securities laws,<br \/>\n     (B) the HSR Act and any related governmental request thereunder, and<br \/>\n     (C) any other applicable law and (iv) execute or deliver any additional<br \/>\n     instruments necessary to consummate the transactions contemplated by, and<br \/>\n     to fully carry out the purposes of, this Agreement. The Company and the<br \/>\n     Buyer shall cooperate with each other in connection with the making of all<br \/>\n     such filings, including providing copies of all such documents to the non-<br \/>\n     filing party and its advisors prior to filing and, if requested, to accept<br \/>\n     all reasonable additions, deletions or changes suggested in connection<br \/>\n     therewith. The Company and the Buyer shall use their respective reasonable<br \/>\n     efforts to furnish to each other all information required for any<br \/>\n     application or other filing to be made pursuant to the rules and<br \/>\n     regulations of any applicable law (including all information required to be<br \/>\n     included in the Proxy Statement and the Registration Statement) in<br \/>\n     connection with the transactions contemplated by this Agreement.<\/p>\n<p>(b)  Subject to the terms hereof, the Buyer and the Company agree, and shall<br \/>\n     cause each of their respective Subsidiaries, to cooperate and to use their<br \/>\n     respective reasonable efforts to obtain any government clearances or<br \/>\n     approvals required for Closing under the HSR Act, the Sherman Act, as<br \/>\n     amended, the Clayton Act, as amended, the Federal Trade Commission Act, as<br \/>\n     amended, and any other federal, state or foreign law or, regulation or<br \/>\n     decree designed to prohibit, restrict or regulate actions <\/p>\n<p>                                       39<\/p>\n<p>     for the purpose or effect of monopolization or restraint of trade<br \/>\n     (collectively &#8220;Antitrust Laws&#8221;), to respond to any government requests for<br \/>\n     information under any Antitrust Law, and to contest and resist any action,<br \/>\n     including any legislative, administrative or judicial action, and to have<br \/>\n     vacated, lifted, reversed or overturned any decree, judgment, injunction or<br \/>\n     other order (whether temporary, preliminary or permanent) (an &#8220;Antitrust<br \/>\n     Order&#8221;) that restricts, prevents or prohibits the consummation of the<br \/>\n     Merger or any other transactions contemplated by this Agreement under any<br \/>\n     Antitrust Law. The parties hereto will consult and cooperate with one<br \/>\n     another, and consider in good faith the views of one another, in connection<br \/>\n     with any analyses, appearances, presentations, memoranda, briefs,<br \/>\n     arguments, opinions and proposals made or submitted by or on behalf of any<br \/>\n     party hereto in connection with proceedings under or relating to any<br \/>\n     Antitrust Law. The Buyer shall be entitled to direct any proceedings or<br \/>\n     negotiations with any Governmental Entity relating to any of the foregoing,<br \/>\n     provided that it shall afford the Company a reasonable opportunity to<br \/>\n     participate therein. Notwithstanding anything to the contrary in this<br \/>\n     Section, neither the Buyer nor any of its Subsidiaries shall be required to<br \/>\n     (i) divest any of their respective businesses, product lines or assets, or<br \/>\n     to take or agree to take any other action or agree to any limitation, that<br \/>\n     could reasonably be expected to have a material adverse effect on the Buyer<br \/>\n     or on the Buyer combined with the Company after the Effective Time or<br \/>\n     (ii) take any action under this Section if the United States Department of<br \/>\n     Justice or the United States Federal Trade Commission authorizes its staff<br \/>\n     to seek a preliminary injunction or restraining order to enjoin<br \/>\n     consummation of the Merger.<\/p>\n<p>(c)  Each of the Company and the Buyer shall give (or shall cause their<br \/>\n     respective Subsidiaries to give) any notices to third parties, and use, and<br \/>\n     cause their respective Subsidiaries to use, their reasonable efforts to<br \/>\n     obtain any third party consents related to or required in connection with<br \/>\n     the Merger that are (A) necessary to consummate the transactions<br \/>\n     contemplated hereby, (B) disclosed or required to be disclosed in Section<br \/>\n     6.6(c) of the Company Disclosure Schedule or the Buyer Disclosure Schedule,<br \/>\n     as the case may be, or (C) required to prevent a Company Material Adverse<br \/>\n     Effect or a Buyer Material Adverse Effect from occurring prior to or after<br \/>\n     the Effective Time.<\/p>\n<p>6.7  Public Disclosure.  The Buyer and the Company shall each use its reasonable<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nefforts to consult with the other before issuing any press release or otherwise<br \/>\nmaking any public statement with respect to the Merger or this Agreement and<br \/>\nshall not issue any such press release or make any such public statement prior<br \/>\nto using such efforts, except as may be required by law.<\/p>\n<p>6.8  Tax-Free Reorganization.  The Buyer and the Company shall each use its<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nreasonable efforts to cause the Merger to be treated as a reorganization within<br \/>\nthe meaning of Section 368(a) of the Code.  The parties hereto hereby adopt this<br \/>\nAgreement as a plan of reorganization.<\/p>\n<p>                                       40<\/p>\n<p>6.9  Affiliate Agreements.  Upon the execution of this Agreement, the Company<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nwill provide the Buyer with a list of those persons who are, in the Company&#8217;s<br \/>\nreasonable judgment, &#8220;affiliates&#8221; of the Company, within the meaning of Rule 145<br \/>\n(each such person who is an &#8220;affiliate&#8221; of the Company within the meaning of<br \/>\nRule 145 is referred to as an &#8220;Affiliate&#8221;) promulgated under the Securities Act<br \/>\n(&#8220;Rule 145&#8221;).  The Company shall provide to the Buyer such information and<br \/>\ndocuments as the Buyer shall reasonably request for purposes of reviewing such<br \/>\nlist and shall notify the Buyer in writing regarding any change in the identity<br \/>\nof its Affiliates prior to the Closing Date.  The Company shall use its<br \/>\nreasonable efforts to deliver or cause to be delivered to the Buyer prior to the<br \/>\nmailing of the Proxy Statement from each of its Affiliates, an executed<br \/>\nAffiliate Agreement, in substantially the form appended hereto as Exhibit C (the<br \/>\n&#8220;Affiliate Agreement&#8221;).<\/p>\n<p>6.10  Nasdaq National Market Listing.  The Buyer shall file with the Nasdaq<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nNational Market a Notification Form for Listing of Additional Shares with<br \/>\nrespect to the Buyer Common Stock issuable in connection with the Merger.<\/p>\n<p>6.11  Company Stock Plans and the Company Warrants.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  At the Effective Time, each outstanding and unvested Company Stock Option<br \/>\n     under Company Stock Plans shall terminate in accordance with their<br \/>\n     respective terms and the terms of the Company Stock Plans.<\/p>\n<p>(b)  The Buyer shall take all corporate action necessary for the substitution of<br \/>\n     options pursuant to optionee elections as contemplated in Section 6.11,<br \/>\n     including the reservation for issuance of a sufficient number of shares of<br \/>\n     Buyer Common Stock for delivery upon exercise of such substituted options.<br \/>\n     As soon as practicable after the Effective Time, the Buyer shall file a<br \/>\n     registration statement on Form S-8 (or any successor form) or another<br \/>\n     appropriate form with respect to the shares of Buyer Common Stock subject<br \/>\n     to such substituted options and shall use its best efforts to maintain the<br \/>\n     effectiveness of such registration statement or registration statements<br \/>\n     (and maintain the current status of the prospectus or prospectuses<br \/>\n     contained therein) for so long as such options remain outstanding.  It is<br \/>\n     intended that the Company Stock Options assumed by Buyer shall qualify<br \/>\n     following the Effective Time as incentive stock options (as defined in<br \/>\n     Section 422 of the Code) to the extent the Company Stock Options qualified<br \/>\n     as incentive stock options immediately prior to the Effective Time and this<br \/>\n     Section 6.11 shall be construed consistent with such intent.<\/p>\n<p>(c)  At the Effective Time, by virtue of the Merger, each Company Warrant<br \/>\n     outstanding immediately prior to the Effective Time shall be automatically<br \/>\n     assumed by Buyer and converted into a warrant to acquire, on the same terms<br \/>\n     and conditions as were applicable under such Company Warrant, the same<br \/>\n     number of shares of Buyer Common Stock (rounded down to the nearest whole<br \/>\n     share) as the holder of such Company Warrant would have been entitled to<br \/>\n     receive pursuant to the <\/p>\n<p>                                       41<\/p>\n<p>     Merger had such holder exercised such Company Warrant in full immediately<br \/>\n     prior to the Effective Time, at a price per share (rounded up to the<br \/>\n     nearest whole cent) of Buyer Common Stock equal to (A) the aggregate<br \/>\n     exercise price for the shares of Company Common Stock otherwise purchasable<br \/>\n     pursuant to such Company Warrant divided by (B) the aggregate number of<br \/>\n     shares of Buyer Common Stock deemed purchasable pursuant to such Company<br \/>\n     Warrant (each, as so adjusted, an &#8220;Adjusted Warrant&#8221;). Prior to the<br \/>\n     Effective Time, Buyer shall take all necessary actions for the assumption<br \/>\n     of the Company Warrants and their conversion into Adjusted Warrants,<br \/>\n     including the reservation, issuance and quotation of Buyer Common Stock in<br \/>\n     a number at least equal to the number of shares of Buyer Common Stock that<br \/>\n     will be subject to the Adjusted Warrants.<\/p>\n<p>(d)  Prior to the Effective Time, the Board of Directors of the Company shall<br \/>\n     take all necessary actions pursuant to and in accordance with the Company<br \/>\n     Stock Plans and the instruments evidencing the Company Stock Options to<br \/>\n     provide for the treatment of the Company Stock Options as provided in<br \/>\n     Schedule 6.11. Except for the elections of optionees&#8217; contemplated by<br \/>\n     Schedule 6.11, no consent of the holders of Company Stock Options is<br \/>\n     required in connection with such actions..<\/p>\n<p>(e)  Subject to the Company&#8217;s compliance with Section 6.11(d), the Buyer shall<br \/>\n     permit holders of vested Company Stock Options to elect to substitute such<br \/>\n     options for options to acquire shares of Buyer Common Stock in accordance<br \/>\n     with Schedule 6.11(e).<\/p>\n<p>6.12  Stockholder Litigation.  Until the earlier of the termination of this<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nAgreement in accordance with its terms or the Effective Time, the Company shall<br \/>\ngive the Buyer the opportunity to participate in the defense or settlement of<br \/>\nany stockholder litigation against the Company or its Board of Directors<br \/>\nrelating to this Agreement or any of the transactions contemplated by this<br \/>\nAgreement, and shall not settle any such litigation without the Buyer&#8217;s prior<br \/>\nwritten consent, which will not be unreasonably withheld or delayed.<\/p>\n<p>6.13  Indemnification.<br \/>\n      &#8212;&#8212;&#8212;&#8212;&#8212; <\/p>\n<p>(a)  From and after the Effective Time, the Buyer shall, to the fullest extent<br \/>\n     permitted by law, cause the Surviving Corporation, for a period of six<br \/>\n     years from the Effective Time, to honor all of the Company&#8217;s obligations to<br \/>\n     indemnify and hold harmless each present and former director and officer of<br \/>\n     the Company (the &#8220;Indemnified Parties&#8221;), against any costs or expenses<br \/>\n     (including attorneys&#8217; fees), judgments, fines, losses, claims, damages,<br \/>\n     liabilities or amounts paid in settlement incurred in connection with any<br \/>\n     claim, action, suit, proceeding or investigation, whether civil, criminal,<br \/>\n     administrative or investigative, arising out of or pertaining to matters<br \/>\n     existing or occurring at or prior to the Effective Time, whether asserted<br \/>\n     or claimed prior <\/p>\n<p>                                       42<\/p>\n<p>     to, at or after the Effective Time, to the extent that such obligations to<br \/>\n     indemnify and hold harmless exist on the date of this Agreement.<\/p>\n<p>(b)  In the event the Surviving Corporation or any of its successors or assigns<br \/>\n     (i) consolidates with or merges into any other person and shall not be the<br \/>\n     continuing or surviving corporation or entity of such consolidation or<br \/>\n     merger or (ii) transfers all or substantially all of its properties and<br \/>\n     assets to any person in a single transaction or a series of transactions,<br \/>\n     then, and in each such case, Buyer will either guaranty the indemnification<br \/>\n     obligations referred to in this Section 6.13 or will make or cause to be<br \/>\n     made proper provision so that the successors and assigns of the Surviving<br \/>\n     Corporation assume the indemnification obligations described herein for the<br \/>\n     benefit of the Indemnified Parties.<\/p>\n<p>(c)  The provisions of this Section 6.13 are (i) intended to be for the benefit<br \/>\n     of, and will be enforceable by, each of the Indemnified Parties and (ii) in<br \/>\n     addition to, and not in substitution for, any other rights to<br \/>\n     indemnification or contribution that any such person may have by contract<br \/>\n     or otherwise.<\/p>\n<p>                                  ARTICLE VII<br \/>\n                             CONDITIONS TO MERGER<\/p>\n<p>7.1  Conditions to Each Party&#8217;s Obligation To Effect the Merger.  The respective<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nobligations of each party to this Agreement to effect the Merger shall be<br \/>\nsubject to the satisfaction prior to the Closing Date of the following<br \/>\nconditions:<\/p>\n<p>(a)  Stockholder Approval.  The Company Voting Proposal shall have been approved<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     and adopted at the Company Meeting, at which a quorum is present, by the<br \/>\n     affirmative vote of the holders of a majority of the shares of the Company<br \/>\n     Common Stock outstanding on the record date for the Company Meeting.<\/p>\n<p>(b)  HSR Act.  The waiting period applicable to the consummation of the Merger<br \/>\n     &#8212;&#8212;-<br \/>\n     under the HSR Act shall have expired or been terminated.<\/p>\n<p>(c)  Governmental Approvals.  Other than the filings provided for by Section<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     1.1, all authorizations, consents, orders or approvals of, or declarations<br \/>\n     or filings with, or expirations of waiting periods imposed by, any<br \/>\n     Governmental Entity, the failure of which to file, obtain or occur is<br \/>\n     reasonably likely to have a Buyer Material Adverse Effect or a Company<br \/>\n     Material Adverse Effect shall have been filed, been obtained or occurred.<\/p>\n<p>(d)  Registration Statement.  The Registration Statement shall have become<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     effective under the Securities Act and shall not be the subject of any stop<br \/>\n     order or proceedings seeking a stop order.<\/p>\n<p>                                       43<\/p>\n<p>(e)  No Injunctions.  No Governmental Entity of competent jurisdiction shall<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     have enacted, issued, promulgated, enforced or entered any order, executive<br \/>\n     order, stay, decree, judgment or injunction (each an &#8220;Order&#8221;) or statute,<br \/>\n     rule or regulation which is in effect and which has the effect of making<br \/>\n     the Merger illegal or otherwise prohibiting consummation of the Merger.<\/p>\n<p>7.2  Additional Conditions to Obligations of the Buyer and the Transitory<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nSubsidiary.  The obligations of the Buyer and the Transitory Subsidiary to<br \/>\n&#8212;&#8212;&#8212;-<br \/>\neffect the Merger are subject to the satisfaction of each of the following<br \/>\nadditional conditions, any of which may be waived in writing exclusively by the<br \/>\nBuyer and the Transitory Subsidiary:<\/p>\n<p>(a)  Representations and Warranties.  The representations and warranties of the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     Company set forth in this Agreement shall be true and correct (i) as of the<br \/>\n     date of this Agreement (except to the extent such representations and<br \/>\n     warranties are specifically made as of a particular date, in which case<br \/>\n     such representations and warranties shall be true and correct as of such<br \/>\n     date) and (ii) as of the Closing Date as though made on and as of the<br \/>\n     Closing Date (except (x) to the extent such representations and warranties<br \/>\n     are specifically made as of a particular date, in which case such<br \/>\n     representations and warranties shall be true and correct as of such date,<br \/>\n     (y) for changes contemplated by this Agreement and (z) where the failures<br \/>\n     to be true and correct (without regard to any materiality, Company Material<br \/>\n     Adverse Effect or knowledge qualifications contained therein), individually<br \/>\n     or in the aggregate, have not had, and are not reasonably likely to have, a<br \/>\n     Company Material Adverse Effect); and the Buyer shall have received a<br \/>\n     certificate signed on behalf of the Company by the chief executive officer<br \/>\n     and the chief financial officer of the Company to such effect.<\/p>\n<p>(b)  Performance of Obligations of the Company.  The Company shall have<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     performed in all material respects all obligations required to be performed<br \/>\n     by it under this Agreement at or prior to the Closing Date; and the Buyer<br \/>\n     shall have received a certificate signed on behalf of the Company by the<br \/>\n     chief executive officer and the chief financial officer of the Company to<br \/>\n     such effect.<\/p>\n<p>(c)  Tax Opinion.  The Buyer shall have received a written opinion from Hale and<br \/>\n     &#8212;&#8212;&#8212;&#8211;<br \/>\n     Dorr LLP, counsel to the Buyer, to the effect that the Merger will be<br \/>\n     treated for federal income tax purposes as a tax-free reorganization within<br \/>\n     the meaning of Section 368(a) of the Code; provided that if Hale and Dorr<br \/>\n     LLP does not render such opinion, this condition shall nonetheless be<br \/>\n     deemed satisfied if Morrison &amp; Foerster LLP or PricewaterhouseCoopers LLP<br \/>\n     renders such opinion to the Buyer (it being agreed that the Buyer and the<br \/>\n     Company shall each provide reasonable cooperation, including making<br \/>\n     reasonable representations, to Hale and Dorr LLP, Morrison &amp; Foerster LLP<br \/>\n     or PricewaterhouseCoopers LLP, as the case may be, to enable them to render<br \/>\n     such opinion).<\/p>\n<p>                                       44<\/p>\n<p>(d)  Third Party Consents.  The Company shall have obtained all consents and<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     approvals of third parties to the Buyer referred to in Section 7.2(d) of<br \/>\n     the Company Disclosure Schedule.<\/p>\n<p>(e)  Resignations.  The Buyer shall have received copies of the resignations,<br \/>\n     &#8212;&#8212;&#8212;&#8212;<br \/>\n     effective as of the Effective Time, of each director of the Company and its<br \/>\n     Subsidiaries.<\/p>\n<p>(f)  Security Procedure Documentation.  The Buyer shall have received from the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n     Company in a form reasonably satisfactory to the Buyer the documentation<br \/>\n     referred to in Section 7.2(f) of the Company Disclosure Schedule with<br \/>\n     respect to the data center and Technology Systems of the Company.<\/p>\n<p>(g)  Notice. The Company shall have given to each holder of a Company Stock<br \/>\n     &#8212;&#8212;<br \/>\n     Option reasonable notice in order to permit such optionholder to exercise<br \/>\n     such option prior to its termination in accordance with the terms of the<br \/>\n     Company Stock Plans and the grants and awards thereunder.<\/p>\n<p>(h)  Company Stock Plans.  The Company shall have taken all actions contemplated<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n     by Section 6.11(f) of this Agreement.<\/p>\n<p>(i)  Contracts.  The Company shall have obtained all amendments and terminations<br \/>\n     &#8212;&#8212;&#8212;-<br \/>\n     of the agreements set forth in Schedule 7.2(i) of the Buyer Disclosure<br \/>\n     Schedule in a form reasonably satisfactory to the Buyer.<\/p>\n<p>7.3  Additional Conditions to Obligations of the Company.  The obligation of the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nCompany to effect the Merger is subject to the satisfaction of each of the<br \/>\nfollowing additional conditions, any of which may be waived, in writing,<br \/>\nexclusively by the Company:<\/p>\n<p>(a)  Representations and Warranties.  The representations and warranties of the<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     Buyer and the Transitory Subsidiary set forth in this Agreement shall be<br \/>\n     true and correct (i) as of the date of this Agreement (except to the extent<br \/>\n     such representations are specifically made as of a particular date, in<br \/>\n     which case such representations and warranties shall be true and correct as<br \/>\n     of such date) and (ii) as of the Closing Date as though made on and as of<br \/>\n     the Closing Date (except (x) to the extent such representations and<br \/>\n     warranties are specifically made as of a particular date, in which case<br \/>\n     such representations and warranties shall be true and correct as of such<br \/>\n     date, (y) for changes contemplated by this Agreement and (z) where the<br \/>\n     failures to be true and correct (without regard to any materiality, Buyer<br \/>\n     Material Adverse Effect or knowledge qualifications contained therein),<br \/>\n     individually or in the aggregate, have not had, and are not reasonably<br \/>\n     likely to have, a Buyer Material Adverse Effect); and the Company shall<br \/>\n     have received a certificate signed on behalf of the Buyer by the chief<br \/>\n     executive officer or the chief financial officer of the Buyer to such<br \/>\n     effect.<\/p>\n<p>                                       45<\/p>\n<p>(b)  Performance of Obligations of the Buyer and the Transitory Subsidiary.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n     The Buyer and Sub shall have performed in all material respects all<br \/>\n     obligations required to be performed by them under this Agreement at or<br \/>\n     prior to the Closing Date, and the Company shall have received a<br \/>\n     certificate signed on behalf of the Buyer by the chief executive officer or<br \/>\n     the chief financial officer of the Buyer to such effect.<\/p>\n<p>(c)  Tax Opinion.  The Company shall have received the opinion of Morrison &amp; &#8212;&#8212;&#8212;&#8211;<br \/>\n     Foerster LLP, counsel to the Company, or PricewaterhouseCoopers LLP, to the<br \/>\n     effect that the Merger will be treated for federal income tax purposes as a<br \/>\n     tax-free reorganization within the meaning of Section 368(a) of the Code;<br \/>\n     provided that if Morrison &amp; Foerster LLP or PricewaterhouseCoopers LLP does<br \/>\n     not render such opinion, this condition shall nonetheless be deemed<br \/>\n     satisfied if Hale and Dorr LLP renders such opinion to the Company (it<br \/>\n     being agreed that the Buyer and the Company shall each provide reasonable<br \/>\n     cooperation, including making reasonable representations, to Morrison &amp; Foerster LLP, Hale and Dorr LLP or PricewaterhouseCoopers LLP, as the case<br \/>\n     may be, to enable them to render such opinion).<\/p>\n<p>                                 ARTICLE VIII<br \/>\n                           TERMINATION AND AMENDMENT<\/p>\n<p>8.1  Termination.  This Agreement may be terminated at any time prior to the<br \/>\n     &#8212;&#8212;&#8212;&#8211;<br \/>\nEffective Time (with respect to Sections 8.1(b) through 8.1(g), by written<br \/>\nnotice by the terminating party to the other party), whether before or, subject<br \/>\nto the terms hereof, after adoption of this Agreement by the stockholders of the<br \/>\nCompany or the stockholder of the Transitory Subsidiary:<\/p>\n<p>(a)  by mutual written consent of the Buyer, Transitory Subsidiary and the<br \/>\n     Company; or<\/p>\n<p>(b)  by either the Buyer or the Company if the Merger shall not have been<br \/>\n     consummated by August 31, 2000 (the &#8220;Outside Date&#8221;) (provided that the<br \/>\n     right to terminate this Agreement under this Section 8.1(b) shall not be<br \/>\n     available to any party whose failure to fulfill any obligation under this<br \/>\n     Agreement has been a principal cause of or resulted in the failure of the<br \/>\n     Merger to occur on or before such date); or<\/p>\n<p>(c)  by either the Buyer or the Company if a Governmental Entity of competent<br \/>\n     jurisdiction shall have issued a nonappealable final order, decree or<br \/>\n     ruling or taken any other nonappealable final action, in each case having<br \/>\n     the effect of permanently restraining, enjoining or otherwise prohibiting<br \/>\n     the Merger; or<\/p>\n<p>(d)  by either the Buyer or the Company if at the Company Meeting (including any<br \/>\n     adjournment or postponement), the requisite vote of the stockholders of <\/p>\n<p>                                       46<\/p>\n<p>     the Company in favor of the Company Voting Proposal shall not have been<br \/>\n     obtained (provided that the right to terminate this Agreement under this<br \/>\n     Section 8.1(d) shall not be available to any party seeking termination who<br \/>\n     at the time is in breach of or has failed to fulfill its obligations under<br \/>\n     this Agreement); or<\/p>\n<p>(e)  by the Buyer, if: (i) the Board of Directors of the Company shall have<br \/>\n     failed to recommend approval of the Company Voting Proposal in the Proxy<br \/>\n     Statement or shall have withdrawn or modified its recommendation of the<br \/>\n     Company Voting Proposal; (ii) the Board of Directors of the Company shall<br \/>\n     have approved or recommended to the stockholders of the Company an<br \/>\n     Alternative Transaction (as defined in Section 8.3(e)); (iii) an<br \/>\n     Alternative Transaction shall have been announced or otherwise publicly<br \/>\n     known and the Board of Directors of the Company shall have (A) failed to<br \/>\n     recommend against acceptance of such Alternative Transaction by its<br \/>\n     stockholders within ten (10) days of delivery of a written request from the<br \/>\n     Buyer for such action or (B) failed to reconfirm its approval and<br \/>\n     recommendation of this Agreement and the transactions contemplated hereby<br \/>\n     within ten (10) days of delivery of a written request from the Buyer for<br \/>\n     such action or (iv) a tender offer or exchange offer for 20% or more of the<br \/>\n     outstanding shares of the Company Common Stock is commenced (other than by<br \/>\n     the Buyer or an Affiliate of the Buyer) and the Board of Directors of the<br \/>\n     Company recommends that the stockholders of the Company tender their shares<br \/>\n     in such tender or exchange offer or, within ten (10) days after such tender<br \/>\n     or exchange offer, fails to recommend against acceptance of such offer or<br \/>\n     takes no position with respect to the acceptance thereof; or<\/p>\n<p>(f)  by either the Buyer or the Company, if there has been a breach or failure<br \/>\n     to perform of any representation, warranty, covenant or agreement on the<br \/>\n     part of the other party set forth in this Agreement, which breach or<br \/>\n     failure to perform (i) causes the conditions set forth in Section 7.2(a) or<br \/>\n     7.2(b) (in the case of termination by the Buyer) or Section 7.3(a) or<br \/>\n     7.3(b) (in the case of termination by the Company) not to be satisfied, and<br \/>\n     (ii) shall not have been cured within 20 days following receipt by the<br \/>\n     breaching party or party failing to perform written notice of such breach<br \/>\n     from the other party; or<\/p>\n<p>(g)  by the Company if (i) the Company after the date hereof has received an<br \/>\n     unsolicited Acquisition Proposal that its Board of Directors has determined<br \/>\n     after consultation with its financial advisor is a Superior Proposal,<br \/>\n     (ii) the Company has complied with all of the provisions of Section<br \/>\n     6.1(a)(A), (iii) the Board of Directors of the Company has determined in<br \/>\n     good faith after consultation with its outside legal counsel that<br \/>\n     termination of this Agreement is necessary for such Board of Directors to<br \/>\n     fulfill with its fiduciary duties under applicable law, and (iv) the<br \/>\n     Company, contemporaneously with, and as a condition to, its termination of<br \/>\n     this Agreement, pays to Buyer the fee and expenses provided for in Section<br \/>\n     8.3.<\/p>\n<p>                                       47<\/p>\n<p>8.2  Effect of Termination.  In the event of termination of this Agreement as<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nprovided in Section 8.1, this Agreement shall immediately become void and there<br \/>\nshall be no liability or obligation on the part of the Buyer, the Company, the<br \/>\nTransitory Subsidiary or their respective officers, directors, stockholders or<br \/>\nAffiliates, except as set forth in Sections 3.26, 5.3, 8.3 and Article IX;<br \/>\nprovided that any such termination shall not relieve any party from liability<br \/>\nfor any willful breach of this Agreement (which includes without limitation the<br \/>\nmaking of any representation or warranty by a party in this Agreement that the<br \/>\nparty knew was not true and accurate when made) and, Sections 3.26, 5.3, 8.3 and<br \/>\nArticle IX of this Agreement and the Confidentiality Agreement shall remain in<br \/>\nfull force and effect and survive any termination of this Agreement.<\/p>\n<p>8.3  Fees and Expenses.<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8211; <\/p>\n<p>(a)  Except as set forth in this Section 8.3, all fees and expenses incurred in<br \/>\n     connection with this Agreement and the transactions contemplated hereby<br \/>\n     shall be paid by the party incurring such fees and expenses, whether or not<br \/>\n     the Merger is consummated; provided however, that the Company and the Buyer<br \/>\n     shall share equally all fees and expenses, other than attorneys&#8217; fees,<br \/>\n     incurred with respect to the printing and filing of the Proxy Statement<br \/>\n     (including any related preliminary materials) and the Registration<br \/>\n     Statement and any amendments or supplements thereto.<\/p>\n<p>(b)  The Company shall pay the Buyer up to $500,000 as reimbursement for<br \/>\n     expenses of the Buyer actually incurred relating to the transactions<br \/>\n     contemplated by this Agreement prior to termination (including, but not<br \/>\n     limited to, fees and expenses of the Buyer&#8217;s counsel, accountants and<br \/>\n     financial advisors, but excluding any discretionary fees paid to such<br \/>\n     financial advisors), upon the termination of this Agreement by the Buyer<br \/>\n     pursuant to Section 8.1(b) as a result of the failure to satisfy the<br \/>\n     condition set forth in Section 7.2(a); or by the Buyer or the Company<br \/>\n     pursuant to Section 8.1(d) under circumstances in which no fee is payable<br \/>\n     to Buyer under Section 8.3(c).<\/p>\n<p>(c)  The Company shall pay the Buyer a termination fee of $20,000,000 upon the<br \/>\n     earliest to occur of the following events:<\/p>\n<p>(i)  the termination of this Agreement by the Buyer pursuant to Section 8.1(e);<br \/>\n     or<\/p>\n<p>(ii) the termination of this Agreement by the Buyer pursuant to Section 8.1(f)<br \/>\n     as a result of a breach of the provisions of Section 6.1 or 6.5; or<\/p>\n<p>(iii)the termination of this Agreement by the Company pursuant to Section<br \/>\n     8.1(g).<\/p>\n<p>                                       48<\/p>\n<p>     If the Buyer or the Company terminates this Agreement pursuant to Section<br \/>\n8.1(d) and, at or prior to such termination a bona fide proposal for an<br \/>\nAlternative Transaction with respect to the Company shall have been publicly<br \/>\nannounced, the Company shall pay to the Buyer, upon such termination, a<br \/>\ntermination fee of $10,000,000.  If such termination fee shall have become<br \/>\npayable to the Buyer pursuant to the preceding sentence and, within 12 months<br \/>\nafter such termination, the Company shall enter into a definitive agreement with<br \/>\nrespect to an Alternative Transaction or an Alternative Transaction involving<br \/>\nthe Company shall be consummated, the Company shall pay to the Buyer an<br \/>\nadditional fee of $10,000,000 upon the execution and delivery of such definitive<br \/>\nagreement or consummation, as the case may be.<\/p>\n<p>(d)  If one party fails to promptly pay to the other any expense reimbursement<br \/>\n     or fee due hereunder, the defaulting party shall pay the costs and expenses<br \/>\n     (including legal fees and expenses) in connection with any action,<br \/>\n     including the filing of any lawsuit or other legal action, taken to collect<br \/>\n     payment, together with interest on the amount of any unpaid fee at the<br \/>\n     publicly announced prime rate of Fleet Bank, N.A. plus five percent per<br \/>\n     annum, compounded quarterly, from the date such expense reimbursement or<br \/>\n     fee was required to be paid.<\/p>\n<p>(e)  As used in this Agreement, &#8220;Alternative Transaction&#8221; means either (i) a<br \/>\n     transaction pursuant to which any person (or group of persons) other than<br \/>\n     the Buyer or its affiliates (a &#8220;Third Party&#8221;), acquires more than 20% of<br \/>\n     the outstanding shares of the Company Common Stock pursuant to a tender<br \/>\n     offer or exchange offer or otherwise, (ii) a merger or other business<br \/>\n     combination involving the Company pursuant to which any Third Party<br \/>\n     acquires more than 20% of the outstanding shares of Company Common Stock or<br \/>\n     of the entity surviving such merger or business combination, (iii) any<br \/>\n     other transaction pursuant to which any Third Party acquires control of<br \/>\n     assets (including for this purpose the outstanding equity securities of<br \/>\n     Subsidiaries of the Company, and the entity surviving any merger or<br \/>\n     business combination including any of them) of the Company having a fair<br \/>\n     market value equal to more than 20% of the fair market value of all the<br \/>\n     assets of the Company immediately prior to such transaction, or (iv) any<br \/>\n     public announcement by a Third Party of a proposal, plan or intention to do<br \/>\n     any of the foregoing or any agreement to engage in any of the foregoing;<br \/>\n     provided, however, that all references in this subsection (e) to &#8220;20%&#8221;<br \/>\n     &#8212;&#8212;&#8211;  &#8212;&#8212;-<br \/>\n     shall mean &#8220;50%&#8221; for purposes of the second paragraph of Section 8.3(c).<\/p>\n<p>8.4  Amendment.  This Agreement may be amended by the parties hereto, by action<br \/>\n     &#8212;&#8212;&#8212;<br \/>\ntaken or authorized by their respective Boards of Directors, at any time before<br \/>\nor after approval of the matters presented in connection with the Merger by the<br \/>\nstockholders of the Company or the Transitory Subsidiary, but, after any such<br \/>\napproval, no amendment shall be made which by law requires further approval by<br \/>\nsuch stockholders without such further approval.  Any agreement on the part of a<br \/>\nparty <\/p>\n<p>                                       49<\/p>\n<p>hereto to any such extension or waiver shall be valid only if set forth in a<br \/>\nwritten instrument signed on behalf of such party. This Agreement may not be<br \/>\namended except by an instrument in writing signed on behalf of each of the<br \/>\nparties hereto.<\/p>\n<p>8.5  Extension; Waiver.  At any time prior to the Effective Time, the parties<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\nhereto, by action taken or authorized by their respective Boards of Directors,<br \/>\nmay, to the extent legally allowed, (i) extend the time for the performance of<br \/>\nany of the obligations or other acts of the other parties hereto, (ii) waive any<br \/>\ninaccuracies in the representations and warranties contained herein or in any<br \/>\ndocument delivered pursuant hereto and (iii) waive compliance with any of the<br \/>\nagreements or conditions contained herein. Any agreement on the part of a party<br \/>\nhereto to any such extension or waiver shall be valid only if set forth in a<br \/>\nwritten instrument signed on behalf of such party.<\/p>\n<p>                                  ARTICLE IX<br \/>\n                                 MISCELLANEOUS<\/p>\n<p>9.1  Nonsurvival of Representations and Warranties.  The respective<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nrepresentations and warranties of the Company, the Buyer and the Transitory<br \/>\nSubsidiary contained in this Agreement or in any instrument delivered pursuant<br \/>\nto this Agreement shall expire with, and be terminated and extinguished upon,<br \/>\nthe Effective Time.<\/p>\n<p>9.2  Notices.  All notices and other communications hereunder shall be in<br \/>\n     &#8212;&#8212;-<br \/>\nwriting and shall be deemed duly delivered (i) four business days after being<br \/>\nsent by registered or certified mail, return receipt requested, postage prepaid,<br \/>\nor (ii) one business day after being sent for next business day delivery, fees<br \/>\nprepaid, via a reputable nationwide overnight courier service, in each case to<br \/>\nthe intended recipient as set forth below:<\/p>\n<p>(a)  if to the Buyer or Transitory Subsidiary, to<\/p>\n<p>               CMGI, Inc.<br \/>\n               100 Brickstone Square<br \/>\n               Andover, Massachusetts 01810<br \/>\n               Attn:  General Counsel<br \/>\n               Telecopy: (978) 684-3601<\/p>\n<p>               with a copy to:<\/p>\n<p>               Hale and Dorr LLP<br \/>\n               60 State Street<br \/>\n               Boston, MA 02109<br \/>\n               Attn:  Mark G. Borden, Esq.<br \/>\n               Telecopy:  (617) 526-5000<\/p>\n<p>(b)  if to the Company, to<\/p>\n<p>                                       50<\/p>\n<p>               UBID, Inc.<br \/>\n               8550 Bryn Mawr Avenue, Suite 200<br \/>\n               Chicago, Illinois 60631<br \/>\n               Attn:  President<br \/>\n               Telecopy: (773) 272-4051<\/p>\n<p>               with a copy to:<\/p>\n<p>               Morrison &amp; Foerster LLP<br \/>\n               19900 MacArthur Blvd.<br \/>\n               Irving, CA  92612<br \/>\n               Attn:  Robert M. Mattson, Jr., Esq.<br \/>\n               Telecopy:  (949) 251-0900<\/p>\n<p>Any party may give any notice or other communication hereunder using any other<br \/>\nmeans (including personal delivery, messenger service, telecopy, telex, ordinary<br \/>\nmail or electronic mail), but no such notice or other communication shall be<br \/>\ndeemed to have been duly given unless and until it actually is received by the<br \/>\nparty for whom it is intended.  Any party may change the address to which<br \/>\nnotices and other communications hereunder are to be delivered by giving the<br \/>\nother parties notice in the manner herein set forth.<\/p>\n<p>9.3  Entire Agreement.   This Agreement (including the Schedules and Exhibits<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nhereto and the documents and instruments referred to herein that are to be<br \/>\ndelivered at the Closing) constitutes the entire agreement among the parties<br \/>\nhereto and supersedes any prior understandings, agreements or representations by<br \/>\nor among the parties hereto, or any of them, written or oral, with respect to<br \/>\nthe subject matter hereof; provided that the Confidentiality Agreement shall<br \/>\nremain in effect in accordance with its terms.<\/p>\n<p>9.4  No Third Party Beneficiaries.  Except as provided in Section 6.13, this<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\nAgreement is not intended, and shall not be deemed, to confer any rights or<br \/>\nremedies upon any person other than the parties hereto and their respective<br \/>\nsuccessors and permitted assigns, to create any agreement of employment with any<br \/>\nperson or to otherwise create any third-party beneficiary hereto.<\/p>\n<p>9.5  Assignment.  Neither this Agreement nor any of the rights, interests or<br \/>\n     &#8212;&#8212;&#8212;-<br \/>\nobligations under this Agreement may be assigned or delegated, in whole or in<br \/>\npart, by operation of law or otherwise by any of the parties hereto without the<br \/>\nprior written consent of the other parties, and any such assignment without such<br \/>\nprior written consent shall be null and void, except that the Buyer and\/or the<br \/>\nTransitory Subsidiary may assign this Agreement to any direct or indirect wholly<br \/>\nowned Subsidiary of the Buyer without consent of the Company, provided that the<br \/>\nBuyer shall remain liable for all of its obligations under this Agreement.<br \/>\nSubject to the preceding sentence, this <\/p>\n<p>                                       51<\/p>\n<p>Agreement shall be binding upon, inure to the benefit of, and be enforceable by,<br \/>\nthe parties hereto and their respective successors and permitted assigns.<\/p>\n<p>9.6  Severability.  Any term or provision of this Agreement that is invalid or<br \/>\n     &#8212;&#8212;&#8212;&#8212;<br \/>\nunenforceable in any situation in any jurisdiction shall not affect the validity<br \/>\nor enforceability of the remaining terms and provisions hereof or the validity<br \/>\nor enforceability of the offending term or provision in any other situation or<br \/>\nin any other jurisdiction.  If the final judgment of a court of competent<br \/>\njurisdiction declares that any term or provision hereof is invalid or<br \/>\nunenforceable, the parties agree hereto that the court making such determination<br \/>\nshall have the power to limit the term or provision, to delete specific words or<br \/>\nphrases, or to replace any invalid or unenforceable term or provision with a<br \/>\nterm or provision that is valid and enforceable and that comes closest to<br \/>\nexpressing the intention of the invalid or unenforceable term or provision, and<br \/>\nthis Agreement shall be enforceable as so modified.  In the event such court<br \/>\ndoes not exercise the power granted to it in the prior sentence, the parties<br \/>\nhereto agree to replace such invalid or unenforceable term or provision with a<br \/>\nvalid and enforceable term or provision that will achieve, to the extent<br \/>\npossible, the economic, business and other purposes of such invalid or<br \/>\nunenforceable term.<\/p>\n<p>9.7  Counterparts and Signature.  This Agreement may be executed in two or more<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\ncounterparts, each of which shall be deemed an original but all of which<br \/>\ntogether shall be considered one and the same agreement and shall become<br \/>\neffective when counterparts have been signed by each of the parties hereto and<br \/>\ndelivered to the other parties, it being understood that all parties need not<br \/>\nsign the same counterpart.  This Agreement may be executed and delivered by<br \/>\nfacsimile transmission.<\/p>\n<p>9.8  Interpretation.  When reference is made in this Agreement to an Article or<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\na Section, such reference shall be to an Article or Section of this Agreement,<br \/>\nunless otherwise indicated.  The table of contents, table of defined terms and<br \/>\nheadings contained in this Agreement are for convenience of reference only and<br \/>\nshall not affect in any way the meaning or interpretation of this Agreement.<br \/>\nThe language used in this Agreement shall be deemed to be the language chosen by<br \/>\nthe parties hereto to express their mutual intent, and no rule of strict<br \/>\nconstruction shall be applied against any party.  Whenever the context may<br \/>\nrequire, any pronouns used in this Agreement shall include the corresponding<br \/>\nmasculine, feminine or neuter forms, and the singular form of nouns and pronouns<br \/>\nshall include the plural, and vice versa.  Any reference to any federal, state,<br \/>\nlocal or foreign statute or law shall be deemed also to refer to all rules and<br \/>\nregulations promulgated thereunder, unless the context requires otherwise.<br \/>\nWhenever the words &#8220;include&#8221;, &#8220;includes&#8221; or &#8220;including&#8221; are used in this<br \/>\nAgreement, they shall be deemed to be followed by the words &#8220;without<br \/>\nlimitation&#8221;.<\/p>\n<p>9.9  Governing Law.  This Agreement shall be governed by and construed in<br \/>\n     &#8212;&#8212;&#8212;&#8212;-<br \/>\naccordance with the internal laws of the State of Delaware without giving effect<br \/>\nto any choice or conflict of law provision or rule (whether of the State of<br \/>\nDelaware or any other <\/p>\n<p>                                       52<\/p>\n<p>jurisdiction) that would cause the application of laws of any jurisdictions<br \/>\nother than those of the State of Delaware.<\/p>\n<p>9.10  Remedies.  Except as otherwise provided herein, any and all remedies<br \/>\n     &#8212;&#8212;&#8212;<br \/>\nherein expressly conferred upon a party will be deemed cumulative with and not<br \/>\nexclusive of any other remedy conferred hereby, or by law or equity upon such<br \/>\nparty, and the exercise by a party of any one remedy will not preclude the<br \/>\nexercise of any other remedy.  The parties hereto agree that irreparable damage<br \/>\nwould occur in the event that any of the provisions of this Agreement were not<br \/>\nperformed in accordance with their specific terms or were otherwise breached.<br \/>\nIt is accordingly agreed that the parties shall be entitled to an injunction or<br \/>\ninjunctions to prevent breaches of this Agreement and to enforce specifically<br \/>\nthe terms and provisions hereof this being in addition to any other remedy to<br \/>\nwhich they are entitled at law or in equity.<\/p>\n<p>9.11  Waiver of Jury Trial.  EACH OF THE BUYER, THE TRANSITORY SUBSIDIARY AND<br \/>\n     &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\nTHE COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION,<br \/>\nPROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE)<br \/>\nARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED<br \/>\nHEREBY OR THE ACTIONS OF THE BUYER, THE TRANSITORY SUBSIDIARY OR THE COMPANY IN<br \/>\nTHE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT OF THIS AGREEMENT.<\/p>\n<p>9.12  Forum.  Each of the parties hereto (i) consents to submit itself to the<br \/>\n     &#8212;&#8212;<br \/>\npersonal jurisdiction of any Federal court located in the State of Delaware or<br \/>\nany Delaware state court in the event any dispute arises out of this Agreement<br \/>\nor any of the transactions contemplated by this Agreement, (ii) agrees that it<br \/>\nwill not attempt to deny or defeat such personal jurisdiction by motion or other<br \/>\nrequest for leave from any such court, and (iii) agrees that it will not bring<br \/>\nany action relating to this Agreement or any of the transactions contemplated by<br \/>\nthis Agreement in any court other than a Federal court sitting in the State of<br \/>\nDelaware or a Delaware state court.<\/p>\n<p>                           [Signature Page to follow]<\/p>\n<p>                                       53<\/p>\n<p>     IN WITNESS WHEREOF, the Buyer, the Transitory Subsidiary and the Company<br \/>\nhave caused this Agreement to be signed by their respective officers thereunto<br \/>\nduly authorized as of the date first written above.<\/p>\n<p>                                    CMGI, INC.<\/p>\n<p>                                    By: \/s\/ Andrew J. Hajducky III<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Title: Executive Vice President,<br \/>\n                                           Chief Financial Officer<br \/>\n                                           and Treasurer<\/p>\n<p>                                    SENLIX CORPORATION<\/p>\n<p>                                    By: \/s\/ Andrew J. Hajducky III<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Title: Executive Vice President,<br \/>\n                                           Chief Financial Officer<br \/>\n                                           and Treasurer<\/p>\n<p>                                    UBID, INC.<\/p>\n<p>                                    By: \/s\/ Gregory Jones<br \/>\n                                        &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<br \/>\n                                    Title: Chief Executive Officer<\/p>\n<p>                                      54<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[7128],"corporate_contracts_industries":[9417],"corporate_contracts_types":[9622,9626],"class_list":["post-43015","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-cmgi-inc","corporate_contracts_industries-financial__holding","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43015","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43015"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43015"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43015"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}